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Summary 
To understand transmissible human diseases, disciplines such as epidemiology and 
the surveillance of affected cases are as essential as the knowledge about the pathogenesis 
and the course of a disease. Epidemiologists categorize and estimate factors for public 
health risks by taking metadata into account including geographic aspects, health and social 
states to study a disease transmission and prevent further cases. In addition, a focus on the 
causative agents itself is necessary in order to understand their ecology and hence their 
virulence traits. The causative agents for a severe pneumonia named Legionnaires’ disease 
(LD) are bacteria of the genus Legionella. The putative sources of LD infection are any 
aerosol-generating natural or man-made fresh water systems. Due to this ubiquitous 
distribution of legionellae, it is difficult to find the source of infection. Therefore, it is 
necessary to isolate the bacterium from the suffering patients to further characterize it in the 
laboratory and to compare the clinical isolates with isolates obtained from probable 
environmental sources.  
The predominant species isolated from LD patients is Legionella pneumophila 
serogroup (Sg) 1. Intensive genotyping of L. pneumophila Sg1 isolates by using the current 
gold standard method, the sequence-based typing scheme (SBT), revealed limitations in 
the discrimination of several sequence types (ST) which could not be compensated for by 
additional phenotypic typing scheme. In practical terms, this means that several clones or 
STs are disproportional frequently found in both, patients and water systems, and cannot 
be distinguished by current methods. Therefore, a distorted picture of endemic and globally-
spread clones is generated and current typing methods cannot add substantial information 
during the identification of the infectious source. The aim of this thesis is to develop and 
implement new typing methods for L. pneumophila isolates with a higher resolution than the 
gold standard methods.  
A DNA-DNA hybridization based microarray was designed and equipped with probes 
that target specifically L. pneumophila virulence factors and genes that are involved in the 
biosynthesis of lipopolysaccharide structures. Legionellae can be subgrouped on the basis 
of their lipopolysaccharide structures. Here, the usually phenotypic characterization of 
L. pneumophila Sg1 is successfully transmitted to a DNA-based genotypic method. 
Furthermore, the detailed validation of the DNA-microarray revealed a higher discriminatory 
power in comparison to the gold standard methods. It enables previously indistinguishable 
clones to be subdivided, providing valuable information about probable sources of infection. 
The second new tool for typing of L. pneumophila is based on the core genome of 
the bacteria. An extended SBT-scheme was extracted from the core genome and 
accordingly named core genome multilocus sequence typing (cgMLST). This genome wide 
gene-by-gene typing approach allows a high genomic resolution of L. pneumophila isolates 
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by retaining epidemiological concordance. A major advantage of this genome-based 
method is the detection of large recombination events within the analysed genomes, which 
is, so far, reserved for whole genome sequencing. The population structure of legionellae 
is largely driven by recombination and horizontal gene transfer rather than by spontaneous 
mutations. Therefore, the detection of recombination events is essential for typing of 
L. pneumophila isolates. In addition, the cgMLST-scheme assigns a core genome 
sequence type to the analysed isolate and allows backwards compatibility with the current 
SBT-scheme. 
Both methods proved to be fast, reliable and robust typing methods through their 
application during outbreak investigations. Furthermore, both systems are particularly 
suited as routine molecular typing tools for the surveillance of single cases. The raw data 
are verified and translated into uniform portable codes, which enables the easy transfer and 
comparison of results. The standardized and portable quality of the results of both methods 
enables the establishment of a curated global database. This qualifies both methods as 
potential new gold standard methods for the genotyping of L. pneumophila isolates. 
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Zusammenfassung 
Zu den essentiellen Grundlagen, die notwendig sind um Infektionskrankheiten zu 
verstehen, gehören neben den Kenntnissen zur Pathogenese und zum Krankheitsverlauf 
auch die Epidemiologie. Sie fokussiert sich auf die Überwachung von Krankheitsfällen und 
kategorisiert gesundheitliche Risikofaktoren, unter Berücksichtigung geographischer, 
krankheitsspezifischer und sozialer Aspekte, um die Ausbreitung der Krankheit zu 
untersuchen und weitere Fälle zu verhindern. Ebenso wichtig bei der Ergründung von 
Infektionskrankheiten sind fundierte Kenntnisse über den Krankheitserreger selbst. Sie sind 
notwendig, um die Ökologie und dadurch die Virulenz der Pathogene zu verstehen. Das 
verursachende Pathogen der Legionärskrankheit, einer schweren Pneumonie, sind 
Bakterien der Gattung Legionella. Potentielle Infektionsquellen für die Legionella-
Pneumonie sind jene natürlichen und künstlichen Frisch- und Süßwassersysteme, aus 
denen Aerosole entstehen können. Aufgrund dieser ubiquitären Verteilung von Legionellen 
ist es dringend erforderlich das Bakterium aus erkrankten Patienten zu isolieren und im 
Labor zu analysieren. Erst der Vergleich von Patientenisolaten mit Isolaten aus möglichen 
Infektionsquellen ermöglicht die Identifizierung von Infektionsquellen.  
Patienten, die an einer Legionella-Pneumonie erkrankten, wurden größtenteils durch 
die Art Legionella pneumophila Serogruppe 1 (Sg1) infiziert. Das intensive Genotypisieren 
von L. pneumophila Sg1-Isolaten durch sequenzbasiertes Typisieren (SBT), dem aktuellen 
Goldstandard der Legionellentypisierung, zeigte eine starke Einschränkung in der 
Diskriminationsfähigkeit einiger Sequenztypen. Weiterführende phänotypische 
Typisierungsmethoden können diese Problem häufig nicht mehr kompensiert. Im 
Umkehrschluss bedeutet dies, dass einzelne Klone und Sequenztypen überproportional 
häufig in Patienten und Wassersystemen gefunden werden, da sie durch aktuelle 
Typisierungsmethoden nicht unterschieden werden können. So entsteht ein verzerrtes Bild 
von endemisch und teilweise global vorkommenden Sequenztypen. Die aktuellen 
Typisierungsmethoden sind folglich bei der Suche nach Infektionsquellen nur bedingt von 
Nutzen. Das Ziel dieser Doktorarbeit ist, neue Typisierungsmethoden mit höherem 
Auflösungspotential als die aktuellen Methoden für L. pneumophila Isolate zu entwickeln 
um diese in Routine- als auch Ausbruchsituationen einzusetzen.  
Ein Microarray, basierend auf DNA-DNA Hybridisierung, wurde entworfen und mit 
Sonden ausgestattet, die spezifisch für Gene von Virulenzfaktoren und der 
Lipopolysaccharidbiosynthese von L. pneumophila sind. Legionellen können auf Basis ihrer 
Lipopolysaccharidstruktur in Subgruppen eingeteilt werden. Diese bislang phänotypische 
Charakterisierung von L. pneumophila Sg1 ist hier erstmals erfolgreich auf eine 
genotypsiche Methode übertragen und im Labor etabliert worden. Die detaillierte 
Validierung des DNA-Microarrays zeigt zudem eine höhere Diskriminationsfähigkeit als die 
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aktuellen Referenzmethoden, wodurch wertvolle Informationen über mögliche 
Infektionsquellen erhalten werden.  
Eine weitere neue Methode für die Typisierung von L. pneumophila Sg1 basiert auf 
dem Kerngenom der Bakterien. Bei diesem Gen-für-Gen Typisierungsansatz, welcher 
Kerngenom Multilokus Sequenztypiserung genannt wird (engl.: core genome multilocus 
sequence typing, cgMLST), werden die Gene des Kerngenoms analysiert. Dies ermöglicht 
eine hohe genomische Auflösung von L. pneumophila-Isolaten ohne Verlust der 
epidemiologischen Konkordanz. Ein weiterer großer Nutzen dieser genombasierten 
Methode ist die Detektion von Rekombinationen größerer Genomabschnitte, etwas das 
bisher nur der Gesamtgenomanalyse vorbehalten ist. Da die Populationsstruktur von 
Legionellen größtenteils durch Rekombinationen und horizontalen Gentransfer geprägt ist, 
und weniger durch spontane Mutationen, stellt die Detektion von Rekombinationen einen 
essentiellen Teil bei der Analyse einzelner Isolate dar. Das neue cgMLST-Schema 
ermöglicht zusätzlich die Einteilung von L. pneumophila-Isolaten in sogenannte 
Kerngenomsequenztypen und ermöglicht eine Rückwärtskompatibilität zum aktuellen 
sequenzbasierten Typisierungsschema. 
Beide Methoden überzeugen als schnelle, zuverlässige und robuste 
Typisierungsmethode während ihrer Anwendung bei Legionellenausbrüchen. Des Weiteren 
können sie als Routinemethoden für die Überwachung einzelner Krankheitsfälle eingesetzt 
werden. Für die Entwicklung neuer Methoden ist vor allem eine Vereinheitlichung der 
Rohdaten notwendig. Ein einheitliches Protokoll sowie Dateninterpretation ermöglichen den 
Vergleich und Austausch der ermittelten Ergebnisse. Die standardisierte Qualität der 
Ergebnisse beider Methoden ermöglicht den Aufbau und Pflege globaler Datenbanken. 
Dadurch sind beide Methoden potentielle neue Referenzmethoden für die Genotypisierung 
von L. pneumophila. 
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Part I - Introduction 
Background 
In June 1976, the annual convention of the American Legion was held in 
Philadelphia. Approximately one week after the convention, 182 people, mostly convention 
attendees, suffered from cough and fevers A total of 147 patients were hospitalized due to 
severe pneumonia, the cause of which was unknown, and 29 patients died (Fraser, et al., 
1977). Several months later, the investigation team of the Centers for Disease Control and 
Prevention (CDC) succeeded in isolating the outbreak’s etiological agent – a gram-negative 
non-spore forming bacillus ranging from small rods of 2-3 µm to longer filaments of 8-10 µm. 
This bacterium was initially called Legionnaires’ disease bacterium due to its historical 
association with the American Legion Convention, and was later named 
Legionella pneumophila. Likewise, the pneumonia it causes was named Legionnaires’ 
disease (LD) or legionellosis (McDade, et al., 1977; Brenner, et al., 1979; Horwitz and 
Silverstein, 1980). Retrospective examination determined Legionella spp. as the cause of 
several pneumonia cases dating back to 1947 (McDade, et al., 1977; Glick, et al., 1978; 
McDade, et al., 1979). Since then, 60 species and more than 70 serogroups (Sg) of 
Legionella have been described worldwide (Bajrai, et al., 2016; Ishizaki, et al., 2016).  
Environment - Ecology 
Legionellae are ubiquitously found in natural and anthropogenic freshwater 
environments such as cooling towers (CT), spas and drinking water distribution systems 
(van Heijnsbergen, et al., 2015). The optimum temperature for growth is from 35 °C to 37 °C 
(Feeley, et al., 1978; Kusnetsov, et al., 1996). However, legionellae have also been found 
at temperatures as low as 10 °C and as high as 70 °C (Fliermans, et al., 1981; Tison and 
Seidler, 1983; Lesnik, et al., 2016). In aqueous environments, legionellae are able to 
colonize persisting biofilms (Declerck, 2010). Their development is characterised by a 
biphasic cycle that comprises a replicative exponential phase form (EPF) and a 
transmissive stationary form (SPF). Certain environmental factors trigger these extracellular 
forms. This causes them to enter for instance the ‘viable but non-culturable’ (VBNC) state, 
which is characterised by a low metabolic activity, or to form long filaments (FF) (Faulkner 
and Garduno, 2002; Robertson, et al., 2014; Kirschner, 2016). In addition, legionellae are 
able to parasitize protozoa such as amoeba that graze on biofilms (Declerck, 2010). After 
internalisation by protozoa, legionellae evade lysosomal degradation and survive within 
vacuoles. From within these vacuoles, the pathogen secretes more than 300 effector 
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proteins into the host cell via a Dot/Icm type IV translocation system. These effectors 
intercept the endoplasmatic reticulum (ER)-Golgi traffic, recruit ER markers and remodel 
the host to form its own replicative niche named Legionella containing vacuole (LCV), which 
results in a highly infectious and stress resistant mature intracellular form (MIF) (Ensminger, 
2016). After replication, the infected and apoptotic host cell lyses and a planktonic 
transmissive form of the bacterium is released into the environment, where it either infects 
other hosts or becomes sessile within biofilms communities. Recent studies have reported 
the Caenorhabditis nematodes as a natural host for L. pneumophila, which may become 
infected upon ingestion of a Legionella-containing protozoan (Brassinga, et al., 2010; 
Hellinga, et al., 2015; Rasch, et al., 2016). Furthermore, legionellae, especially the species 
L. longbeachae, are frequently isolated from soil or composted matter (Steele, et al., 1990; 
Den Boer, et al., 2007).  
Infection of the respiratory tract 
Another rather accidental host is the respiratory tract of mammals. Although several 
studies demonstrated that animals may become infected with legionellae, the main concern 
of the pathogen on human has focused on human infections (Fitzgeorge, et al., 1983; 
Boldur, et al., 1987; Fabbi, et al., 1993; Hägele, et al., 2000; Dorer, et al., 2006; Harding, et 
al., 2012). Legionellae can enter the human lung via aerosolised water droplets. These 
aerosols can be emitted by any water-bearing system in contact with air, such as CTs, spas, 
showers, fountains, humidifiers and waste water treatments plants, etc. (Figure 1) (Berendt, 
1980; van Heijnsbergen, et al., 2015; Allegra, et al., 2016). Consequently, small Legionella-
containing aerosol droplets can reach the lower respiratory tract where they encounter 
alveolar macrophages. These macrophages can subsequently be infected by the pathogen 
in a similar way to amoeba. Macrophages and amoeba are professional phagocytes that 
generally eliminate phagocytosed targets by means of lysosomaI degradation. Studies on 
animals, human cell lines and amoeba showed a similar mode of infection by 
L. pneumophila. It has been argued that the long co-evolution of L. pneumophila with its 
natural host amoeba lead to the selection of an infection mechanism that allows its uptake 
and replication within other similar phagocytosing cells (Escoll, et al., 2013). Nevertheless, 
the infectious dose of aerosols lacks adequate evaluation. Several effects have been 
described, including the particle size, the packing of aerosols with infectious bacteria, the 
replicative form of infectious bacteria, the charge of the droplet and/or the charge of the 
bacterium’s outer membrane and the device that’s emits aerosols (Berendt, 1980; Dennis 
and Lee, 1988; Gaboriaud, et al., 2008; Gosselin, et al., 2011; Hines, et al., 2014). However, 
it is generally assumed that the human lung represents an evolutionary dead end for 
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legionellae, although the first putative person-to-person transmission was reported recently 
(Correia, et al., 2016).  
Clinical symptoms 
Legionellae cause two forms of respiratory infections: a non-pneumonic mild form 
named Pontiac fever and the LD mentioned above, with its clinical manifestation of an 
atypical pneumonia. Pontiac fever is a self-limiting illness with influenza-like symptoms (e.g. 
muscle pain, cough, fever, headache and chills) and usually lasts up to five days. The 
incubation time is 24 to 48 hours. So far, no deaths have been reported due to Pontiac 
fever. The more severe form, LD, features influenza-like symptoms as well as symptoms of 
severe pneumonia, including shortness of breath, nausea, vomiting, diarrhoea, chest pains, 
confusion and the coughing of blood. The incubation period is from two to ten days, and in 
some cases up to 20 days (WHO, 2007). In general, healthy people seldom become 
infected with legionellae. However, several host factors have been described that 
predispose one to becoming infected with LD. There is a clear increase of reported cases 
in people older than 50 years, and males are affected twice to four times as frequently as 
females. Only a few cases have been reported in children (Phin, et al., 2014). Smokers or 
former smokers, as well as people with chronic lung diseases (e.g. chronic obstructive 
respiratory disease [COPD]), are more susceptible. Furthermore, people who are 
immunosuppressed due to illnesses such as cancer, diabetes, and kidney failures, and 
Figure 1: Schematic route of Legionella dissemination from natural and artificial reservoirs.  Legionella 
can enter the fresh water system from environmental systems such as rivers or waste water treatment plants. 
Colonization of fresh water systems by Legionella can occur under optimal conditions that enable the 
amplification of legionellae. Aerosols can be distributed by e.g. private and public spas, cooling towers on 
buildings and plants, fountains, dental units and showers. Large apartment buildings, hotels, cruise ships and 
hospitals with branched and often unclear water networks possess more likely niches that are favorable for 
Legionella-amplification. Another, water-independent source of infection especially for the species 
L. longbeachae is (potting) soil. 
© Kosthorst/Petzold/Lück 
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people who take immunosuppressive or anti-inflammatory medications are prone to 
infection by legionellae.  
Epidemiology 
Legionnaires’’ disease accounts for 2 to 8 % of community acquired pneumonia 
(CAP) (von Baum, et al., 2008; Bartlett, 2011). However, since surveillance systems for 
legionellae differ between countries, and are completely missing in some countries, the 
incidence of Legionella-pneumonia is generally thought to be higher. In several countries 
LD is a notifiable disease. Surveillance schemes have been implemented in the USA, 
Canada, New Zealand, Australia, Japan and Singapore. In Europe, surveillance is 
organized by the European Centre for Disease Prevention and Control (ECDC). The crude 
notification rate in Europe is 14 cases per million inhabitants. However, the rates vary from 
one in Poland to 51 per million inhabitants in Slovenia. In recent years, the number of 
reported LD cases in Europe has increased steadily, from 5,000 cases in 2011 to more than 
7,000 cases in 2015. France, Spain, Italy and Germany report the most cases (68 % of 
cases reported in Europe) (ECDC, 2016). Similarly, the notification rate in the USA has 
increased from four in 2000 to eleven cases per million inhabitants in 2009, with a higher 
notification rate in the north-eastern states than in other states (CDC, 2011). A total of 5.000 
cases were reported in the USA in 2015, with a fatality rate of 8 %, which is identical to that 
of Europe (CDC, 2015; ECDC, 2016).  
The majority (70 %) of LD cases are sporadic single CAP cases. These patients 
acquired LD in any setting other than their domestic home, such as while travelling or during 
a health care stay. Around one fifth of the cases are travel associated (TALD), which means 
these patients had stayed at a public accommodation site (e.g. hotel) for two to ten days 
before the onset of their illness. The LD cases reported in health care settings (e.g. hospitals 
or nursing homes) account for approximately 8 %, while the remaining cases are attributed 
to clusters and outbreaks (Joseph, et al., 2010b; Beaute and ELDSNet, 2017). A cluster 
links two or more cases by space (e.g. accommodation site or work place) and has sufficient 
proximity in time, while outbreaks link cases in space and time (WHO, 2007; European 
Commission, 2012; Beaute and ELDSNet, 2017). In general, LD patients are infected by 
one single strain, although there have been cases reported with dual infections of Legionella 
strains (Wewalka, et al., 2014).  
The European Legionnaires’ Disease Surveillance Network (ELDSNet), which is 
coordinated by the ECDC, operates a platform that gathers a great deal of information on 
LD cases in Europe, with the help of national public health authorities. This means that 
TALDs, clusters and outbreaks can be detected rapidly. Its close contact with regional and 
national public health authorities and vice versa allows a prompt response when anomalies 
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are observed. It provides support materials that enable the public authorities to avoid the 
helplessness that they may face in the case of an LD outbreak. Several tools and guidelines 
assist them in identifying potential contaminated sources (e.g. GIS support, epidemiological 
surveys) and in assessing and minimizing the potential risks (prevention and control 
guidelines). This means that a network of local public health authorities, trained 
epidemiologists, microbiologists and risk assessors can called in order to identify the source 
of contamination and reduce the number of LD cases and fatalities (ECDC, 2012).  
Laboratory analysis 
The mere clinical picture of atypical pneumonia does not confirm legionellae as 
causative agent. Further laboratory analyses are urgently needed to confirm LD. There are 
several national and international guidelines that classify methods according to their 
potential to confirm the disease (CSTE, 2010; European Commission, 2012). The isolation 
of the bacteria by cultivation on selective media represents the most important method and 
is regarded as the ‘gold standard’. Although legionellae have been isolated from blood and 
feces samples, the recommended sampling site for isolating living legionellae is the lower 
respiratory tract such as sputum, tracheal secretions, broncho-alveolar lavages (BAL), etc. 
(Edelstein, et al., 1979; Maiwald, et al., 1998; Rowbotham, 1998; Dunne, et al., 2017). 
Isolated colonies serve as a fundamental basis for further typing methods, which allows the 
detailed comparison of the clinical and environmental isolates. However, the isolation of 
legionellae by cultivation is time-consuming (up to ten days) and is subject to fluctuations 
related to the recovery rate. This is often due to patients’ ongoing antibiotic therapies, which 
kill the antibiotic-sensitive legionellae prior to sampling, and which lowers the chance of 
isolating living bacteria. In addition, legionellae are slow-growing and are demanding 
bacteria with regard to nutrients. A special nutrient formulation that includes charcoal and 
essential supplements such as L-cysteine and ferrous sulfate is needed. Antibiotics are 
often needed to substantially diminish the growth of other respiratory microorganisms, 
hence the sensitivity range for cultivation of <10 to 80 % (Dunne, et al., 2017).  
Therefore, clinicians prefer a rapid diagnosis that allows for adequate treatment. The 
detection of processed antigen (e.g. lipopolysaccharides) in urine samples was initially 
described for patients in Philadelphia the outbreak, 1976 (Berdal, et al., 1979; Sanford, 
1979). The urinary antigen test (UAT) is a fast diagnostic method that allows the 
confirmation of LD within minutes (Dunne, et al., 2017). Since antigen can be even be 
excreted weeks after infection, a laboratory results must be examined in the context of the 
patient’s clinical picture. Although this method is primarily limited to antigen of 
L. pneumophila Sg1, UATs are routinely used and confirm approximately 80 % of LD cases 
(ECDC, 2015b). Another fast and culture-independent method is the detection of legionellae 
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nucleic acid (DNA) by real-time polymerase chain reaction (PCR). This method has shown 
a higher sensitivity (83 %), together with a similar specificity of 90 % in comparison to the 
100 % specificity using culture-based isolation (Cristovam, et al., 2017). Since legionellae 
do not colonize healthy people, a positive PCR-test is always indicative of an infection. 
Several partially multiplex systems have been introduced in recent years that target DNA of 
different Legionella species, but most prominently L. pneumophila and L. pneumophila Sg1 
(Benitez and Winchell, 2013; Mentasti, et al., 2015; Benitez and Winchell, 2016). A recent 
study reported that PCR-based methods outcompetes UAT by detecting up to 30 % more 
LD cases (Avni, et al., 2016).  
The three aforementioned methods rank first when laboratory confirmation of LD is 
required. Other methods, such as seroconversion, single high antibody titers against 
legionellae and direct fluorescent antibody tests (DFA) from respiratory samples, are 
inappropriate methods that lack sensitivity and specificity and should not be used to confirm 
LD cases (Dunne, et al., 2017).  
The methods used to detect and/or isolate legionellae from environmental samples 
are similar. IN general, prior to detection, the capturing and/or the enrichment of the bacteria 
is necessary, for example by centrifugation or the filtration of water samples through 
membranes (ISO 11731, 1998; Villari, et al., 1998; ISO 11731-2, 2008; Reidt, et al., 2011; 
Wunderlich, et al., 2016). With regard to clinical samples, the primary goal for environmental 
samples is to isolate living bacteria on selective media. Furthermore, several PCR systems 
are available for the detection and enumeration of legionellae and are intensively compared 
to the cultivation method (Lee, et al., 2011; ISO 12869, 2012; Edagawa, et al., 2015; Collins, 
et al., 2017). However, intensive discussions that address the effect of the detection of free 
DNA or DNA from dead bacteria in samples are still ongoing and demand a viable-PCR 
(Schnetzinger, et al., 2013; Ditommaso, et al., 2015; Scaturro, et al., 2016).  
Division and typing of legionellae 
Of the 60 valid Legionella species described, half of them were isolated from clinical 
samples (Muder and Yu, 2002; Diederen, 2008; Bajrai, et al., 2016; Ishizaki, et al., 2016). 
However, the species most frequently isolated from respiratory material globally is 
L. pneumophila (95 %). Interestingly, in Australia and New Zealand another species is more 
prominent in clinical samples, where. L. longbeachae accounts for 50 to 70 % of clinical 
isolates and is commonly associated with potting soil (Slaon-Gardner, et al., 2011; Graham, 
et al., 2012).  
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The species L. pneumophila can further be subdivided into 15 serogroups (Sg) 
(Figure 2). This method is based on the structural differences of the lipopolysaccharide 
(LPS) on the bacteria’s outer membrane which can be detected by specific monoclonal 
antibodies (mAb). Joly and colleagues described the potential of mAbs to divide 
L. pneumophila into Sgs that allows the differentiation of isolates from each other. A more 
sophisticated scheme named ‘Dresden panel’ (including mAb 3 of Joly’s scheme) was set 
up by Helbig and colleagues and groups L. pneumophila isolates into 15 serogroups, and 
nine mAb-subgroups of Sg1 (Joly, et al., 1983; Joly, et al., 1986; Helbig, et al., 1997; Helbig, 
et al., 2002).  
Two mAbs (mAb 8/5 and mAb 3/1) proved to be of particular value for epidemiological and 
clinical purposes as the most dominant and virulent strains could be identified. These mAbs 
specifically recognize the Sg1 strains that cause the majority of LD cases (mAb 8/5; 80 % 
of culture-confirmed LD cases) and strains of the Pontiac group (mAb 3/1), respectively. 
This represents 90 % of the Sg1 clinical isolates in CAP and TALD cases (Beaute, et al., 
2013; Phin, et al., 2014; ECDC, 2016). Controversially, mAb 3/1+ isolates are seldom 
isolated from routine water samples (Lück, 2011).  
However, the serotyping of L. pneumophila has limitations with regard to the 
potential for differentiation, initial studies reported (Figure 3). With the advent of genome-
based methods of analysis, a larger spectrum of methods was applied to legionellae, 
basically by the restriction and the separation of DNA. The initial genome-based methods 
mAb 20/1
+    │    -
France/
Allentown
BenidormPhiladelphiaKnoxville
mAb 8/4
+    │    -
mAb 3
+    │    -
mAb 3/1
+    │    -
non-Sg1
mAb 8/5
+    │    -
mAb 8/4
+    │    -
HeyshamBellinghamOxfordOLDA
mAb 26/1
+    │    -
mAb 10/6
+    │    -
Camperdown
mAb 3
+    │    -
Pontiac group non-Pontiac group
mAb-subgroup
Figure 2 The mAb-based subgrouping scheme.  The ‘Dresden panel + mAb3’ allows a hierarchical 
classification of L. pneumophila Sg1 isolates into mAb-subgroups (adapted from Helbig, et al., 2002). 
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for the typing of L. pneumophila Sg1 strains were evaluated in detail in 1999 by the 
European Working Group for Legionella Infections (EWGLI, which in 2012 became ESGLI, 
the affiliated study group of the European Society of Clinical Microbiology and Infectious 
Disease [ESCMID]) (Fry, et al., 1999). Several techniques were validated with regard to 
their discriminatory power and for their epidemiological concordance, using a European 
L. pneumophila strain collection (EUL). The amplified fragment-length polymorphism 
analysis (AFLP) (Valsangiacomo, et al., 1995) and the pulsed-field gel electrophoresis 
(PFGE) using the restriction nuclease SfiI (Lück, et al., 1991) proved to have the highest 
discrimination potential. However, since a discriminatory power value of 0.95 or higher is 
desirable, both methods required mAb-based subgrouping as a pre-screening method for 
acceptable discrimination (Fry, et al., 1999; Van Belkum, et al., 2007). While the molecular 
methods allowed a rapid screening of isolates within single laboratories, the interlaboratory 
exchange of results was unsatisfied, especially when gel-based methods were used. 
Feddersen and colleagues reported a gene-based typing scheme using gyrB for the first 
time, suggesting a higher discriminator potential than PFGE (Feddersen, et al., 2000). This 
scheme would enable the typing of L. pneumophila and simultaneous screening for 
quinolone-resistance determining regions. Nevertheless, it took three more years before the 
multilocus sequence typing (MLST) scheme was adapted for L. pneumophila Sg1, although 
it had already been implemented for highly infectious bacteria. It uses specific PCRs to 
amplify preselected parts of genes prior to sequencing (Maiden, et al., 1998). After quality 
control, the sequences are analyzed. Each variant of a specific gene, also referred to as 
Figure 3: Literature overview of molecular typing of L. pneumophila.  A Medline search for the typing 
methods of L. pneumophila was conducted (Suppl. Table 1). A total of 201 publications were included. Mab-
based subgrouping was initially combined with all the kinds of molecular typing methods, mainly based on 
restriction techniques (1986 to 2007). The introduction of SBT as a typing method in 2003 (completed in 2007 
with seven alleles) gradually replaced these techniques. The limitations of SBT were bypassed by adding 
another method (mainly mAb-subgrouping) or by developing new techniques. The solid line indicates to 
publications (by %) that reported concerns regarding SBT as a single typing method during the surveillance 
studies, case or outbreak reports. 
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allele, is assigned an allele number and each nucleotide polymorphism within an allele 
results in a particular allele number. In this way, a database of allele sequences and their 
corresponding allele numbers is generated, and an allele sequence can be compared to the 
set of known alleles within a database. The same allele number is only assigned to a 
sequence if a sequence matches a known allele sequence for 100 %. Any single 
polymorphism results in a new allele number. Since only one locus is less discriminatory, a 
set of alleles is used. Usually, MLST schemes comprise housekeeping genes that are not 
under selective pressure (Enright and Spratt, 1999; Spratt, 1999). Since the set for 
L. pneumophila contains genes that are virulence associated and are therefore probably 
under higher selective pressure than housekeeping genes, the scheme was named 
‘sequence-based typing’ (SBT) to avoid misunderstandings. The initial set introduced by 
Gaia and colleagues comprised three genes (flaA, proA and mompS). The allele numbers 
were combined into a ternary-code revealing an index of discrimination (IOD) of 0.92, which 
was above that of the AFLP analysis. Once again, the IOD was 0.97 only by adding mAb-
based subgrouping the IOD was 0.97 (Gaia, et al., 2003). The allelic scheme was extended 
to six alleles (IOD of 0.94) in 2005 and then to seven alleles (flaA, pilE, asd, mip, mompS, 
proA, and neuA) in 2007 to order to achieve an IOD of 0.96 (Gaia, et al., 2005; Ratzow, et 
al., 2007; Farhat, et al., 2011). The allele numbers were combined in strict order to an allelic 
profile or sequence type (ST). Since 2005, the SBT scheme has become the established 
method for L. pneumophila genotyping. A web-based platform was built and is curated by 
Public Health England (formerly called the Health Protection Agency), which facilitates a 
quality control for allele sequences, a growing database of allele sequences and STs, and 
further allows the retrieval of allelic profiles (Underwood, et al., 2006). For samples where 
no isolates can be obtained, a nested SBT (nSBT) approach was developed (Ginevra, et 
al., 2009a) in which alleles can be directly amplified in respiratory samples without the need 
for an isolated colony. Currently, 2,471 different STs are recorded in the ESGLI database 
(30th October 2017) (ESGLI, 2015).  
Limitations of ‘gold standard’ typing methods 
In general, the comparison of environmental and clinical isolates is either facilitated 
by using SBT as a single typing tool or, in two consecutive steps, by using mAb-subtyping 
as a pre-screening tool, followed by SBT. When isolates have the same mAb-subgroup, 
they are subsequently typed using SBT. Matching isolates for both methods means the 
identification of the source of infection and implies further actions that depend on the water 
system (e.g. decontamination, risk assessment, construction measures). The introduction 
of SBT as a globally recognized typing method for L. pneumophila was greeted by great 
expectation and surveillance laboratories extolled the robustness and comparability of the 
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method. Several studies were conducted to analyze ST variety in clinical or environmental 
isolates of specific regions or strain collections (Borchardt, et al., 2008; Chasqueira, et al., 
2009; Harrison, et al., 2009; Amemura-Maekawa, et al., 2010; Tijet, et al., 2010). 
Simultaneously, LD surveillance was mainly based on SBT, and not only in Europe (Fry, et 
al., 2007; Joseph and Ricketts, 2010; CDC, 2011; Kozak-Muiznieks, et al., 2014; ECDC, 
2015b). It soon became apparent that particular STs can exist as isolates in almost 
exclusively environmental samples, while others are mainly found in clinical samples. 
Similar tendencies were observed for globally spread STs, i.e. the ST1 clone and endemic 
clones (in Europe: ST23, ST37, ST47, ST62; in Germany, Berlin: ST182) were found in 
distinct areas (Cazalet, et al., 2008; Ginevra, et al., 2009b; Tijet, et al., 2010; Vergnes, et 
al., 2011; Krause, 2014). These results confirmed tentative doubts concerning this method 
as previous genome-based methods had also required an additional technique for higher 
resolution between isolates (Figure 3). Although the number of studies conducted using 
SBT as genetic typing tool increased, the major point of concern was the need for an 
additional typing method. As a result, mAb-subgrouping is still used as a pre-screening tool 
prior to SBT.  
Major drawbacks concerning the identification of a potential source of infection were 
reported for endemic clones that could not be differentiated, even when both, the SBT and 
mAb-subgrouping methods were used. For example, isolates typed as ST1, mAb-subgroup 
OLDA or ST47, mAb-subgroup Allentown/France (especially in Western Europe) were 
frequently found in different kinds of environmental and clinical samples. A clear assignment 
of one environmental reservoir as a source of infection for a clinical case is unreliable. 
Therefore, several environmental sources could be regarded as possible sources of 
infection, even when no space temporal differences are obvious. Therefore, a further, third, 
method of differentiation was required. Laboratories facing these obstacles therefore 
developed other tools to further differentiate these clones. These tools used specific genetic 
elements as targets to differentiate clones. For example, the pathogenicity island (PA-I) was 
used as a target for variable element typing (VET) (Pannier, et al., 2010). The set of virulent 
genes on this PA-I differs between strains of the same clone. A further method uses the 
bacterial antiviral defense system of clustered regularly interspaced short palindromic 
repeats (CRISPR)/CRISPR-associated (Cas), CRISPR-Cas. This genetic region is 
composed of spacers and repeats. By typing the number, order and sequences of theses 
spacers, a spoligotype is assigned to an isolate (Ginevra, et al., 2012). The multiple-locus 
variable number of repeats (VNTR) assay (MLVA) also showed the potential to differentiate 
between clones of the same ST and the mAb-subgroup. The number and size of tandem 
repeats spread throughout the genome is analyzed and, similarly to SBT, allows an allelic 
profile that can be compared between isolates (Pourcel, et al., 2007; Kahlisch, et al., 2010; 
Sobral, et al., 2011). Other laboratories developed microarrays with probes of the 
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L. pneumophila genome in order to verify the specific markers or marker genes found 
exclusively in clinical isolates, or to differentiate isolates of the same ST and mAb-subgroup 
by their clonal origin (Yzerman, et al., 2010; Den Boer, et al., 2013).  
Despite these intense efforts to find a high-resolution typing method that is robust, 
reproducible and reliable, the majority of the tools were not adopted by other laboratories 
and appear to only have one single application. Reasons for this, are the lack of an 
international standardization and the absence of a curated database for the comparison 
and the exchange of results.  
Unexpectedly, Underwood and colleagues revealed that SBT is in fact an optimal 
typing method for L. pneumophila on the basis of the whole genome sequences (WGS) of 
more than 800 different STs. They found that clustering based on WGS data was similar to 
ST-based clustering. They further identified, that L. pneumophila is spiked with recombined 
regions, which are mostly described for regions involved in phenotypical characteristics. 
This may explain the occurrence of different mAb-subtypes within a particular ST and vice 
versa (Underwood, et al., 2013). In the same year, Reuter and colleagues proved the 
feasibility of WGS for the analysis of isolates during an outbreak scenario (Reuter, et al., 
2013).  
Aim of this work 
When this work started in 2013, next-generation sequencing (NGS) represented a 
major improvement in the molecular typing of bacteria and had triggered a wave of 
widespread use. However, the gold standard methods for L. pneumophila were SBT and 
mAb-based subgrouping, both of which demonstrated their limitations for the discrimination 
of several clones. Consequently, this work focus on new methods of molecular typing. It 
addresses issues of the limited molecular discrimination of the current gold standard 
methods and also the lack of standardized interpretation of WGS-data.  
Although NGS is a promising tool that allows a widespread application, routine 
laboratories still cannot afford the second or third generation sequencing techniques. In 
addition, the analysis of NGS-raw data requires experienced staff, especially for the data 
interpretation. Therefore, this work introduces two new methods: a standardized NGS-
based method named core genome MLST and a DNA-microarray that runs on a standard 
laboratory platform.  
Part II reports the successive development of a DNA-DNA hybridization based 
microarray for the molecular typing of L. pneumophila. This microarray can be equipped 
with several hundred probes that hybridize to bacterial DNA. The microarray platform 
includes a reading device with automated data interpretation and is already reported for a 
variety of pathogens such as Staphylococcus spp., Mycobacterium spp., 
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Salmonella enterica, Mycoplasma spp., Brucella spp., or influenza and is established in 
numerous laboratories (Monecke and Ehricht, 2005; Monecke, et al., 2008; Schmoock, et 
al., 2011; Braun, et al., 2012; Ruettger, et al., 2012; Schnee, et al., 2012). The most 
important aspect of this work concentrates on the identification of suitable targets that allow 
a higher discriminatory potential than current methods. An additional aspect is the 
simultaneous assignment of mAb-subgroups to isolates based on the genomic markers on 
the microarray.  
A different aspect of current typing methods is addressed in Part III. Here, NGS data 
were processed and mapped against an extended scheme called cgMLST. However, the 
main concern with regard to NGS is the lack of standardized protocols for DNA extraction, 
sequencing and data interpretation. This problem was tackled by creating a standardized 
protocol for DNA treatment, sequencing and data processing using a fixed target scheme. 
The establishment of a genome-wide gene-by-gene typing approach for L. pneumophila 
was initially described by Moran-Gilad and colleagues (2015). However, this work 
simultaneously evaluates its detailed practical applicability during outbreak investigations in 
Germany.  
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Abstract 
Background 
The lipopolysaccharide (LPS) is the major immuno-dominant antigen of all 
Legionella species including L. pneumophila. Its diversity is the basis for the classification 
of L. pneumophila into serogroups and monoclonal subgroups and is thought to be involved 
in strain specific virulence. The understanding of the genetic basis of the LPS-antigen is 
incomplete. Thus, we analyzed the genetic locus involved in LPS-biosynthesis of 
L. pneumophila serogroup 1 (Sg1) strains with the focus on strain specific gene 
composition. 
 
Results 
The LPS-biosynthesis loci of 14 L. pneumophila Sg1 strains comprise two distinct 
regions: A 15 kb region containing LPS-biosynthesis genes that can be found in all 
L. pneumophila strains and a Sg1-specific 18 kb region. The 15 kb region is highly 
conserved among Sg1 strains as reflected by high homologies of single ORFs and by a 
consistent ORF arrangement. In contrast, the Sg1 specific 18 kb region is variable and 
partially disrupted by phage related genes. We propose that the region spanning from 
ORF 6 to ORF 11 of the Sg1-specific region is likely involved in late LPS-modification. Due 
to the high variability of this small region and various combinations of single ORFs within 
this region a strain specific LPS-structure could be synthesized including modifications of 
legionaminic acid derivates. 
 
Conclusions 
Our data clearly demonstrate that the gene structure of the LPS-biosynthesis locus 
of L. pneumophila Sg1 strains show significant interstrain variability. These data can be 
used for further functional analysis of the LPS synthesis to understand pathogenesis and 
reactivity with monoclonal antibodies. Moreover, variable but strain specific regions can 
serve as basis for the development of novel genotyping assays. 
Background 
Legionella pneumophila is one of 56 described species belonging to the genus 
Legionella of the family Legionellaceae (Pearce, et al., 2012). These gram-negative bacteria 
are ubiquitous inhabitants of natural and manmade aquatic environments where they 
survive parasitically in protozoa like amoeba (Rowbotham, 1980; Fields, et al., 2002) and 
in community structures such as biofilms (Declerck, 2010; Stewart, et al., 2012). 
Additionally, Legionella can infiltrate the human lung via inhaled aerosols (Fraser, 1980; 
Fields, et al., 2002) and subsequently infect alveolar macrophages (Isberg, et al., 2009) 
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which frequently cause a potential fatal pneumonia termed Legionnaires’ disease (LD) 
(McDade, et al., 1977). L. pneumophila strains belonging to the serogroup 1 (Sg1) were 
predominantly reported in LD cases, especially in community acquired and travel-
associated cases (Harrison, et al., 2009; Joseph, et al., 2010b). 
Lipopolysaccharide (LPS) is the major immuno-dominant antigen of all Legionella 
species including L. pneumophila (Ciesielski, et al., 1986). It is the main component 
recognized by patient’s sera and by diagnostic assays in urinary antigen detection (Helbig, 
et al., 2012). The LPS molecule possesses a high degree of diversity and thereby provides 
the basis for the classification of L. pneumophila into serogroups and subgroups by 
monoclonal antibodies (mAb) (Joly, et al., 1983; Helbig, et al., 1997; Helbig, et al., 2007). 
Sg1 strains are subdivided into nine mAb-subgroups using the Dresden monoclonal 
antibody panel (Table 1) (Helbig, et al., 2002). 
The structural characterization of LPS of L. pneumophila identified several specific 
chemical attributes which differs it from the LPS molecules of other Gram-negative bacteria 
(reviewed in Knirel and Valvano, 2011). Particularly the O-antigen homopolymer structure 
consists of an unusual residue, 5-acetamidino-7-acetamido-8-O-acetyl-3, 5, 7, 9-
tetradesoxy-D-glycero-D-galacto-nonulosonic acid (legionaminic acid) and its derivates 
(Knirel, et al., 1994; Zähringer, et al., 1995; Kooistra, et al., 2002a). 
A central step in understanding the correlation of the LPS structure and 
pathogenesis of L. pneumophila was the description of the genetic background of LPS 
molecules by Lüneberg and colleagues (Lüneberg, et al., 2000). More precisely, a genetic 
locus composed of at least 28 open reading frames (ORF) is essential in LPS core 
oligosaccharide biosynthesis and LPS O-chain biosynthesis. The genes of this 31-36 kb 
cluster have characteristic functions required for the synthesis, transport, translocation and 
modification of LPS components. The lag-1 gene of this biosynthesis locus encodes for an 
O-acetyltransferase which is responsible for the 8-O-acetylation of legionaminic acid (Zou, 
et al., 1999). Strains carrying a functional lag-1 synthesize an LPS epitope that reacts with 
Table 1: Monoclonal antibody-based subgrouping of L. pneumophila Sg1 strains using the Dresden 
panel 
mAb-subgroup 8/5 3/1 3 8/4 10/6 20/1 26/1 30/4 
Philadelphia + + - + - - - - 
Allentown/France + + - - - - - +/-a 
Benidorm + + - - - + - - 
Knoxville + + + - - - - - 
OLDA + - - + - +/-a + +/-a 
Oxford + - - + - - - +/-a 
Heysham + - + - - - - - 
Camperdown + - - - - - + + 
Bellingham + - - - + + + + 
: Variable results with different strain 
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the mAb 3/1 (initially named mAb 2 (Joly, et al., 1986)) of the Dresden monoclonal antibody 
panel. This epitope is assumed to contribute to an increased virulence (Zou, et al., 1999) 
since mAb 3/1+ strains represent the most prominent subgroup of clinical Legionella 
isolates. In contrast, strains lacking lag-1 carry mainly deacetylated LPS molecules. These 
mAb 3/1- strains comprise only a small number of clinically identified L. pneumophila strains 
in immunocompetent patients (Harrison, et al., 2009; Joseph, et al., 2010a). 
Besides the mAb 3/1-specific O-acetylation of the legionaminic acid epitope, to date 
it remains elusive how strain specific mAb-reactivities can be explained. Increased 
understanding of the genetic background and structural LPS properties of the different Sg1 
strains could help to comprehend subgroup distributions among clinical and environmental 
isolates (Helbig, et al., 1995; Helbig, et al., 2002; Harrison, et al., 2006; Harrison, et al., 
2009; Reimer, et al., 2010; Amemura-Maekawa, et al., 2012) and would deliver more insight 
in the role of LPS in the L. pneumophila life cycle. 
To achieve this goal, we analyzed the LPS-biosynthesis loci of at least one member 
of each mAb-subgroup (excluding mAb-subgroup Oxford) of the L. pneumophila Sg1. In this 
study we focused on the genetically composition of the loci and putative genotype-
phenotype correlations according to the Dresden panel of mAbs. 
Methods 
Phenotypic and genotypic characterization of L. pneumophila 
strains 
Legionella pneumophila Sg1 strains Camperdown 1 (ATCC 43113), Heysham 1 
(ATCC 43107) (Joly, et al., 1986), Uppsala 3 (Bernander, et al., 2003) and Görlitz 6543 
(Thürmer, et al., 2009) were grown on buffered charcoal yeast extract (BCYE) agar plates 
(Oxoid, Wesel, Germany) for 48 h at 37 °C under a 5 % CO2 atmosphere. Monoclonal 
subgrouping was accomplished using the Dresden panel of mAb as described elsewhere 
(Helbig, et al., 1997; Helbig, et al., 2002). 
DNA extraction and sequence generation 
DNA was extracted using the EZ1 DNA Tissue Kit (Qiagen, Hilden, Germany). Prior 
to sequencing DNA fragments of the LPS-biosynthesis locus were PCR-amplified using 
GoTaq polymerase (Promega, Madison, US-WI) and LPS-specific primers (Suppl. Table 2) 
which were designed based on published L. pneumophila genomes. Initial denaturation was 
carried out at 95 °C for 2 min followed by 30-35 cycles: 95 °C denaturation for 30 s, 
annealing at various temperatures for 1 min and elongation at 72 °C for 1 min/kb. Final 
elongation for 5 min at 72 °C completed the amplification protocol. The PCR result was 
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checked on 1.5 % agarose gel with 5 V/cm (LE Agarose, Biozym, Oldendorf, Germany) and 
purified (MSB Spin PCRapace, Stratec, Birkenfeld, Germany) for sequence reaction. 
Sequencing reactions were accomplished by a cycle-sequencing procedure on an 
automated DNA sequencing machine (ABI Prism 377, Applied Biosystems, Waltham; 
US-MA). 
The LPS-biosynthesis locus of the strain L10/23 was sequenced during a whole 
genome sequencing project. This strain was isolated during a cooling tower related 
outbreak in Ulm (Germany) in 2010 (von Baum, et al., 2010). 
Sequence annotation and analysis 
Obtained sequences of Camperdown 1, Heysham 1, Uppsala 3, Görlitz 6543 and 
L10/23 were assembled using SeqMan (Lasergene 8, DNASTAR, Madison, US-WI) and 
controlled against public databases using BLAST (Altschul, et al., 1997). ORF annotation 
of all analyzed strains was accomplished with GeneMark.hmm (Lukashin and Borodovsky, 
1998) and Artemis (Rutherford, et al., 2000). The annotation and the numbering of ORFs 
was based on the initially described LPS-biosynthesis locus of strain RC1 (mAb-subgroup 
OLDA) (Lüneberg, et al., 2000) and if possible supplemented by further description of 
genes, gene products and their putative functions using BLAST, BLASTP (Altschul, et al., 
1997; Altschul, et al., 2005), the LegionellaScope database of the MicroScope Microbial 
Genome Annotation Platform (Vallenet, et al., 2009) and the Conserved Domain Database 
(Marchler-Bauer, et al., 2011). Since Lüneberg et al. analyzed the strain RC1 which had 
30 ORFs the numbering of ORFs in other L. pneumophila Sg1 strains with deviating ORF 
numbers is not continual (Lüneberg, et al., 2000). The genes iraA (ORF 29) and iraB 
(ORF 30) were not taken into account as part of the LPS-biosynthesis locus. Both formed 
a small 2-gene operon responsible for iron assimilation, infection and virulence 
(Viswanathan, et al., 2000). 
The putative coding regions were compared to already known LPS-biosynthesis 
ORFs of published L. pneumophila strains using the SeqMan program. The LPS-
biosynthesis clusters of the strains were deposited in the EMBL database under the number 
[EMBL: HE980447] for strain Camperdown 1 (mAb-subgroup Camperdown), [EMBL: 
HE980446] for strain Heysham 1 (mAb-subgroup Heysham), [EMBL: HE980445] for strain 
Uppsala 3 (mAb-subgroup Knoxville), [EMBL: HF678227] for strain Görlitz 6543 (mAb-
subgroup Bellingham) and [EMBL: HF545881] for strain L10/23 (mAb-subgroup Knoxville) 
(Table 2). 
Sequence homologies of single ORFs were calculated based on multiple alignments 
using BioNumerics 6.0 (Applied Maths NV, Sint-Martens-Latem, Belgium) and BLASTP 
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(Altschul, et al., 2005). Cluster analysis was performed using the UPGMA method of the 
BioNumerics 6.0 software package. 
The sequences of other LPS-biosynthesis loci were obtained from complete 
genomes of the following strains: Paris (mAb-subgroup Philadelphia) (GenBank: 
NC_006368.1), Lens (mAb-subgroup Benidorm) (GenBank: NC_006369.1), Philadelphia 1 
(mAb-subgroup Philadelphia) (GenBank: NC_002942.5), Alcoy 2300/99 (mAb-subgroup 
Knoxville) (GenBank: NC_014125.1), Corby (mAb-subgroup Knoxville) (GenBank: 
NC_009494.2), Lorraine (mAb-subgroup Allentown) (EMBL: FQ958210), HL 06041035 
(mAb-subgroup Bellingham) (EMBL: FQ958211), RC1 (mAb-subgroup OLDA) (EMBL: 
AJ277755) and 130b (mAb-subgroup Benidorm) (EMBL: FR687201.1) (Table 2) (Lüneberg, 
et al., 2000; Chien, et al., 2004; Cazalet, et al., 2008; Glöckner, et al., 2008; D'Auria, et al., 
2010; Schroeder, et al., 2010; Gomez-Valero, et al., 2011a). Since the genome of 130b is 
a draft version we closed a sequencing gap in scaffold 4 (position 918107 to 918206) using 
PCR and sequencing.  
Table 2: LPS biosynthesis loci obtained from sequenced genomes of L. pneumophila Sg1 strains 
Strain 
mAb 
subgroup Accession no. Reference 
Alcoy 2300/99 Knoxville GenBank: NC_014125.1 (D'Auria, et al., 2010) 
Corby Knoxville GenBank: NC_009494.2 (Glöckner, et al., 2008) 
L10/23 (Ulm)* Knoxville EMBL: HF545881 this study 
Uppsala 3* Knoxville EMBL: HE980445 this study 
Paris Philadelphia GenBank: NC_006368.1 (Cazalet, et al., 2004) 
Philadelphia 1 Philadelphia GenBank: NC_002942.5 (Chien, et al., 2004) 
HL 0604 1035 Bellingham EMBL: FQ958211 (Gomez-Valero, et al., 2011b) 
Görlitz 6543* Bellingham EMBL: HF678227 this study 
Camperdown 1* Camperdown EMBL: HE980447 this study 
Heysham 1* Heysham EMBL: HE980446 this study 
130b (Wadsworth) Benidorm EMBL: FR687201 (FH93HPE01) (Schroeder, et al., 2010) 
Lens Benidorm GenBank: NC_006369.1 (Cazalet, et al., 2004) 
Lorraine Allentown EMBL: FQ958210 (Gomez-Valero, et al., 2011b) 
RC1* OLDA EMBL: AJ277755 (Lüneberg, et al., 2000) 
* only LPS biosynthesis locus sequenced 
 
Results and discussion 
Two regions within the LPS-biosynthesis locus 
To gain insight into the genetic composition and arrangement of the LPS 
biosynthesis locus we analyzed the loci of 14 L. pneumophila Sg1 strains. The strains 
represent members of all mAb–subgroups that can be distinguished by the Dresden 
monoclonal antibody panel (Table 1) besides the extremely rare mAb-subgroup Oxford. The 
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LPS biosynthesis loci of five strains were newly sequenced for this study. These were: 
Camperdown   and Heysham 1 of the rarely found subgroups of the same name (Harrison, 
et al., 2009; Amemura-Maekawa, et al., 2012) and the strains Uppsala 3, Görlitz 6543 and 
L10/23. Eight LPS biosynthesis loci were obtained from complete genomes that have been 
published previously. Furthermore, for strain RC1 (mAb subgroup OLDA) the biosynthesis 
locus was available as well (Table 2). 
The LPS-biosynthesis locus of each of the analyzed L. pneumophila Sg1 strains 
contained at least 28 ORFs and ranged in size from 30,644 bp (strain Lorraine) to 35,888 bp 
(strain 130b) with an average locus size of 33,398 bp respectively. The average ORF size 
within the locus was approximately 1 kb. The complete LPS-biosynthesis locus had a 
slightly lower % GC content (~35 %) than the adjacent regions (~38 %) and the total 
genome (~38.5 %), respectively (Suppl. Table 4). 
Structural and comparative analysis of the loci confirmed a highly conserved 15 kb 
region from wecA (ORF 14) to lpg0748 (ORF 28) according to the Philadelphia1 genome 
as shown previously (Cazalet, et al., 2008). Additionally, all ORFs within this region were 
consistently orientated into the same direction (Figure 4). 
A second region within the locus of 18 kb in size is spanning from lpg0779 (ORF 1) 
to lpg0764 (ORF 13). Here, the structural composition and the orientation of ORFs as well 
as the total amount of putative ORFs was less conserved (Table 3). Interestingly, many 
transposases and phage related genes were present in 8 strains (Figure 4). 
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Figure 4: Structural representation of the LPS-biosynthesis locus. Shown are the LPS-biosynthesis loci of 
14 L. pneumophila Sg1 strains and the corresponding monoclonal subgroup (in brackets). Strains Alcoy 
2300/99, Corby and L10/23, and Paris and Philadelphia 1, respectively had the same genetic structure and 
monoclonal subtype and were therefore shown in one scheme. The numbering of ORFs was adopted by 
(Lüneberg, et al., 2000). A: shows the Sg1-specific 18 kb region (ORFs 1-13) and B: shows the 15 kb region 
(ORFs 14-28). The direction of transcription is indicated by arrowheads. The filled black arrows indicate 
transposases/phage-related proteins. Grey shades and hatched patters serve to distinguish ORFs. Asterisk in 
Uppsala 3, Philadelphia 1 and Paris represents a partial ORF 2 duplication (ORF 2 like) as described by 
(Bernander, et al., 2003). Underlined ORFs 7–11 in strain 130b represent an inversion. Görlitz 6543 carries a 
truncated lag-1 marked with †. 
 
Orf 1 Orf 13-aOrf 9Orf 8Orf 7Orf 6wzmwztOrf 3lag-1Orf 2 Orf 12Orf 11Orf 10*
Uppsala 3 (Knoxville)
Paris, Philadelphia 1 (Philadelphia)
Lens (Benidorm)
Orf 1 Orf 9Orf 8Orf 7Orf 6wzmwztOrf 3lag-1Orf 2 Orf 13-cOrf 11Orf 10 Orf 13-A
130b (Benidorm)
Orf 1 Orf 9Orf 10Orf 11Orf 6wzmwztOrf 3lag-1Orf 2 Orf 13-cOrf 7Orf 8 Orf 13-A
Lorraine (Allentown)
Orf 1 Orf 9Orf 8Orf 7Orf 6wzmwztOrf 3lag-1Orf 2 Orf 11Orf 10 Orf 13-A
RC1 (OLDA)
Orf 1 Orf 9Orf 8Orf 7Orf 6wzmwztOrf 3 Orf 12Orf 2 Orf 11Orf 10 Orf 13-a
HL 06041035 (Bellingham)
Orf 1 Orf 9Orf 8Orf 7Orf 6wzmwztOrf 3 Orf 13-cOrf 2 Orf 11Orf 10 Orf 13-A
Camperdown 1 (Camperdown)
Orf 1 Orf 7Orf 6wzmwztOrf 3Orf 2 Orf 9Orf 8 Orf 12Orf 11Orf 10 Orf 13-a
Heysham 1 (Heysham)
Orf 1 Orf 7Orf 6wzmwztOrf 3Orf 2 Orf 9Orf 8 Orf 12Orf 11Orf 10 Orf 13-a
Orf 1 Orf 13-aOrf 9Orf 8Orf 7Orf 6wzmwztOrf 3lag-1Orf 2 Orf 12Orf 11Orf 10
Alcoy 2300/99, Corby, L10/23 (Knoxville)
Orf 1 Orf 9Orf 8Orf 7Orf 6wzmwztOrf 3lag-1Orf 2 Orf 12Orf 11Orf 10* Orf 13-b
Görlitz 6543 (Bellingham)
Orf 1 Orf 9Orf 8Orf 7Orf 6wzmwztOrf 3 Orf 13-cOrf 2 Orf 11Orf 10 Orf 13-Alag-1†
All Sg1 strains
wecA yvfErmlDrmlBgpirmlAgalE neuDrmlC hisHneuC neuB pseA-likeneuA hisF
Orf 14 Orf 21Orf 19Orf 18Orf 17Orf 16Orf 15 Orf 22Orf 20 Orf 26Orf 23 Orf 24 Orf 28Orf 25 Orf 27
A: 
B: 
1 kb
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The heterogeneous nature of the 18 kb region and the extremely high conserved 
15 kb region found in our study are largely in agreement with earlier results. These proposed 
to separate the locus into a Sg1-specific and a L. pneumophila-specific region (Cazalet, et 
al., 2008; Mérault, et al., 2011). Microarray analysis of Sg1 and non-Sg1 strains have 
identified a 13 kb region (ORF 16-28) which is present in all L. pneumophila strains and a 
20 kb region (ORF 1-15) generally found in all Sg1 strains (Cazalet, et al., 2008). The two 
regions were defined based on the LPS-biosynthesis loci of the Sg1 strain Paris (Cazalet, 
et al., 2004).  
To determine the putative breakpoint between both regions is difficult. However, 
based on our analysis of the structural composition we would rather separate the LPS 
biosynthesis locus between lpg0763 (ORF 13) and wecA (ORF 14). This is in agreement 
with recent data, since the genes wecA (ORF 14) and galE (ORF 15) were demonstrated 
to be present in non-Sg1 strains with lower amino acid similarities when compared to Sg1 
strains (55-61%) (Mérault, et al., 2011). 
The previously mentioned ORF 13 is located next to the breakpoint region. In total, 
four different types of ORFs were found in the analyzed region of Sg1 strains here named 
ORF 13-a, -b, -c and -A. In each of the strains Lens, 130b, HL 06041035 and Görlitz 6543 
two ORFs were found. These strains carried a putative conserved protein of unknown 
function (here referred to as ORF 13-A). A transposase-disrupted ORF 13 A was present in 
strain 130b (Figure 4). Additionally, the strains carried an ORF which shared features of the 
radical S-adenosylmethionine (SAM) superfamily (CDD: cd01335) named ORF 13-c 
(Suppl. Table 3). Interestingly, all these strains lacked the ORF 12. However, even though 
the strain Lorraine lacked ORF 12 as well, it carried only a single ORF 13-A variant. 
A distinct ORF of unknown function with amino acid similarity to ORF 13-A of only 
38 %, here named ORF 13-a, was present in the remaining strains with the exceptions of a 
truncated form in strains RC1, Philadelphia 1 and Paris. Philadelphia 1 and Paris shared 
high similarities with ORF 13-a but a deletion led to a frame shift resulting into three smaller 
fragments (pooled as ORF 13-b). 
A conserved region found in all serogroup 1 strains 
Within the conserved region several genes were found which are proposed to be 
involved in the biosynthesis of the highly acetylated core region which is composed of 
mannose, N-acetyl-glucosamine (GlcNAc), N-acetyl-quinovosamine (QuiNAc) and 
rhamnose residues (Zähringer, et al., 1995). A vast number of ORFs, more specifically 
ORF 21 through 25 and 28, were recently reported to facilitate the biosynthesis of the 
repetitive legionaminic acid residues of the O-antigen (Knirel, et al., 1994; Glaze, et al., 
2008). The pyrodoxal-phosphate dependent aminotransferase (ORF 21), the 
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acetyltransferase neuD (ORF 22) and a dehydratase (lpg0966) located outside of the locus 
are likely to synthesize the precursor molecule of legionaminic acid, UDP-N,N’-
diacetylbacillosamine (UDP-Bac2Ac4Ac) (Schoenhofen, et al., 2006). Contradictory to our 
findings, functions of the neuD products are described highlighting that the 
acetyltransferase is involved in Lag-1-independent O-acetylation of few legionaminic acid 
residues close to the LPS-core of L. pneumophila (Lüneberg, et al., 2000; Knirel, et al., 
2003; Lewis, et al., 2006). Furthermore, the adjacent genes encoding for NeuC (ORF 23), 
NeuB (ORF 24) and NeuA (ORF 25) were recently identified to be involved in the 
subsequent biosynthetic processes converting UDP-Bac2Ac4Ac into CMP-5,7-
diacetamido-3,5,7,9-tetradeoxy-D-glycero-D-talo-nonulosonic acid (CMP-Leg5Ac7Ac) 
(Glaze, et al., 2008). Moreover, the ORF 28 is homologous to the ptmG gene of 
Campylobacter jejuni (Cj1324) which converts the CMP-Leg5Ac7Ac residue to CMP-5-
acetamidino-7-acetamido-3,5,7,9-tetradeoxy-D-glycero-D-talo-nonulosonic acid (CMP-
Leg5Am7Ac) (McNally, et al., 2007), the dominant residue of the O-antigen of non-Sg1 
strains of L. pneumophila (Knirel, et al., 2001). A functional correlation of the ORFs of this 
region is supported by recent transcriptomic data of strain Paris in which the ORFs 21-17 
and 28-22 were transcribed as operons (Sahr, et al., 2012). Since all analyzed Sg1 strains 
and a broad number of non-Sg1 strains carry ORF 28 it can be assumed that CMP-
Leg5Am7Ac is a common residue of the L. pneumophila LPS molecule which might 
subsequently become modified in a mAb-subgroup or even strain specific manner 
(Ledesma, et al., 1995; Farhat, et al., 2011; Mérault, et al., 2011). 
Three clusters of the O-acetyltransferase Lag-1 
A well examined phenotype variation is linked to the presence and absence of the 
lag-1 gene. Lag-1 encodes for an O-acetyltransferase that conferred reactivity with mAb 3/1 
and is exclusively found in Sg1 strains. Our results revealed three clusters of the lag-1 
genes, although without any detectable relation to the mAb-subgroup switch which supports 
recent findings (Kozak, et al., 2009) (Figure 5). Lag-1 was previously reported to be involved 
in mAb-subgroup switches of different strains. However, this was generally due to gene 
deletion or loss-of-function mutations of lag-1 (Lück, et al., 2001; Bernander, et al., 2003; 
Wagner, et al., 2007; Thürmer, et al., 2009). Complete and functional lag-1 genes were 
present in all mAb 3/1+ strains and were absent in all mAb 3/1- strains. Besides that, the 
Philadelphia subgroup strains (Philadelphia 1 and Paris) as well as the Knoxville-subgroup 
strain Uppsala 3 carried a transposase and a partial duplication of ORF 2 adjacent to lag-1. 
Bernander et al. reported the region from ORF 2 to ORF 3 as unstable (Bernander, et al., 
2003). Looping-out of the intermediate located lag-1 gene is assumed to be a potential 
consequence. Under in vitro conditions the deletion of the lag-1 gene occurred at with 
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frequency of 10-6 to 10-7 (C. Lück, unpublished results). Detailed analysis of the region from 
ORF 2 to ORF 3 including lag-1 of these strains revealed remarkably high similarities of 
Uppsala 3 to the Philadelphia-subgroup strains Philadelphia 1 and Paris (>98-100 %) 
whereas the remaining Knoxville-subgroup strains clustered in a different group (Table 3; 
Figure 5). The high similarity of this 4 kb region between strain Uppsala 3 and the strains 
Paris and Philadelphia 1 may indicate horizontal gene transfer of this region. However, this 
had no impact on the specific mAb reactivity for all other analyzed Knoxville-subgroup 
strains. Horizontal gene transfer between strain Paris and Philadelphia 1 was recently 
reported for a large genome fragment which also harbored the LPS biosynthesis locus 
(Gomez-Valero, et al., 2011b). These observations are confirmed by our results since the 
LPS biosynthesis loci of both strains are almost identical in composition, arrangement and 
amino acid similarity (Suppl. Table 3). A truncated lag-1 gene was found in the strain 
Görlitz 6543 (mAb-subgroup Bellingham) as recently reported (Thürmer, et al., 2009). The 
whole gene is present but carries a mutated start codon. Since Görlitz 6543 showed no 
reactivity with mAb 3/1 it was assumed that the mutation significantly impairs the production 
of a functional O-acetyltransferase. Phylogenetic analysis showed 99.9 % amino acid 
similarity of Görlitz 6543 to Corby (mAb-subgroup Knoxville), 130b and Lens (both mAb-
subgroup Benidorm) (Figure 5). 
ABC-transporter genes wzt and wzm as Sg1-specfic marker region 
Noticeable conserved genes within the heterogenic region were wzt (ORF 4) and 
wzm (ORF 5) which are almost identical among all analyzed Sg1 strains (Table 3). Wzm 
encodes for a protein containing a transmembrane domain while wzt encodes for a 
 
Philadelphia 1 (Philadelphia)
Lens (Benidorm)
Alcoy 2300/99 (Knoxville)
Paris (Philadelphia)
Uppsala 3 (Knoxville)
Corby (Knoxville)
L10/23 (Knoxville)
130b (Benidorm)
Lorraine (Allentown)
HL 06041035 (Bellingham)
Philadelphia 1 (Philadelphia)
Lens (Benidorm)
Alcoy 2300/99 (Knoxville)
Paris (Philadelphia)
Camperdown 1 (Camperdown)
Uppsala 3 (Knoxville)
Corby (Knoxville)
L10/23 (Knoxville)
130b (Benidorm)
RC1 (OLDA)
Heysham 1 (Heysham)
Lorraine (Allentown)
HL 06041035 (Bellingham)
Philadelphia 1 (Philadelphia)
Lens (Benidorm)
Alcoy 2300/99 (Knoxville)
Paris (Philadelphia)
Camperdown 1 (Camperdown)
Uppsala 3 (Knoxville)
Corby (Knoxville)
L10/23 (Knoxville)
130b (Benidorm)
RC1 (OLDA)
Heysham 1 (Heysham)
Lorraine (Allentown)
HL 06041035 (Bellingham)
Philadelphia 1 (Philadelphia)
Lens (Benidorm)
Alcoy 2300/99 (Knoxville)
Paris (Philadelphia)
Camperdown 1 (Camperdown)
Uppsala 3 (Knoxville)
Corby (Knoxville)
L10/23 (Knoxville)
130b (Benidorm)
RC1 (OLDA)
Heysham 1 (Heysham)
Lorraine (Allentown)
Görlitz 6543 (Bellingham)†
Görlitz 6543 (Bellingham)
Görlitz 6543 (Bellingham)
Görlitz 6543 (Bellingham)
 A: lag-1 
B: ORF 6 
C: ORF 7 
D: ORF 8 
Figure 5: Dendrogram of variable ORFs.  Multiple amino acid based cluster analysis using UPGMA (BioNumerics, 
Applied Maths NV, Belgium). The phylogenetic trees of gene lag-1 and of the ORFs 6, 7 and 8 are shown. ORF 9 
is identical to the phylogenetic tree of ORF 8 and is therefore not shown. Similarity values and branch distances 
were depicted in percentages [%]. The strain-specific mAb-subgroup is indicated in brackets. The mutated start 
codon of lag-1 of Görlitz 6543 was neglected for similarity analysis and is indicated with †. 
 Part II - Chapter I  
 
26 
nucleotide binding domain of an ABC transporter system which mediates the O-antigen 
translocation across the inner membrane (Greenfield and Whitfield, 2012). Recently, both 
genes were evaluated as marker genes for PCR based discrimination between 
L. pneumophila Sg1 and non-Sg1 strains (Mérault, et al., 2011). The ABC transporter-
dependent O-antigen pathway interacts with WecA (ORF 14), an UDP-GlcNAc-1-
transferase which initiates O-chain biosynthesis at the cytoplasmic site of the inner 
membrane (Greenfield and Whitfield, 2012). The low amino acid similarity of WecA between 
Sg1 and non-Sg1 that was described recently combined with the absence of wzm and wzt 
in non-Sg1 genomes indicate a different O-chain biosynthesis mechanism for non-Sg1 
strains than found in Sg1 strains (Mérault, et al., 2011). 
ORF 6 through 11 involved in O-antigen modification 
The most variable region within the Sg1-specific region in terms of low similarities 
on the amino acid level and the diverse arrangement of single ORFs was found from ORF 6 
to ORF 11. The strains of mAb-subgroup Benidorm 130b and Lens were almost identical 
regarding the amino acid similarities of the single ORFs within the Sg1-specific region. 
Interestingly, strain 130b carried a large inverted fragment containing ORF 7 to ORF 11 
(Figure 4). This region was surrounded by transposases suggesting their potential 
contribution to the inversion. Since the strain 130b showed no altered reactivity pattern 
using the Dresden panel compared to other Benidorm strains it could be stated that the 
inversion had no detectable effect on the LPS phenotype detected by monoclonal 
antibodies. 
The adjacent ORF 6 showed a high degree of variability between L. pneumophila 
Sg1 strains represented by two clusters of low amino acid similarity (<39 %) (Table 4). 
Interestingly, the two analyzed strains of the mAb-subgroup Benidorm, 130b and Lens, 
cluster into two distinct groups. This either indicates that the product of ORF 6 has probably 
no effect on the LPS structure of strains of the same monoclonal subgroup or that it has the 
same function despite low similarity. 
However, ORF 6 products might be involved in the establishment of a mAb-subgroup 
discriminating epitope. More precisely, only the mAb-subgroups Heysham and Knoxville 
react with mAb 3. This indicates a similar epitope which in turn could possibly be traced 
back to specific ORFs within the Sg1-specific region. However, strains of both mAb-
subgroups were highly homologous regarding the whole LPS-biosynthesis with the 
exception of lag-1 which is present in Knoxville strains (Table 3, Table 4). In addition, the 
strain Camperdown 1, not reacting with mAb 3, carried a very similar LPS-biosynthesis 
locus as Heysham 1 and the Knoxville strains. It is the single ORF 6 in which 
Camperdown 1 clusters differently to Heysham 1. It can be assumed that the combination 
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of ORF 6 to 9 which is exclusively found in Knoxville and Heysham strains leads to reactivity 
with mAb 3. Another ORF 6 as found in the genetically very similar strain Camperdown 1 
could alter the LPS epitope and is thereby not recognized by mAb 3. Furthermore, the 
mAb 3 epitope was not influenced by O-acetylation of the legionaminic acid residue since 
the Knoxville strains were mAb 3/1+ and carried the lag-1 gene whereas the strain 
Heysham 1 is negative for both markers. 
Modification of legionaminic acid in transposon mutants 
Two additional ORFs, ORF 8 and ORF 9, within in the highly variable region from 
ORF 6 to ORF 11 are most likely involved in O-antigen modification. The genetic nature of 
the ORF 8 products displayed two different clusters which was comparable to the clustering 
of ORF 9. Both clusters share poor amino acid similarities of 31 % (ORF 8) and 30.7 % 
(ORF 9) (Table 3, Figure 5). These differences in amino acid similarity were also reflected 
by the ORF orientation. Both ORFs were orientated into opposite directions in strains of the 
mAb-subgroups Knoxville, Camperdown and Heysham which form a separate cluster in 
both ORFs (Figure 4). For the remaining mAb-subgroups (Philadelphia, Allentown, 
Benidorm, Bellingham and OLDA) the ORFs are oriented into identical directions. In silico 
analysis of these loci predicted a five-gene operon from ORF 8 to ORF 12 suggesting a 
coupled functional entity (Price, et al., 2005). These strains were also grouped into a single 
cluster. However, recent transcriptomic data obtained from strain Paris revealed a four-gene 
operon which lacks ORF 8 (Sahr, et al., 2012). For all strains regardless of the distance in 
the phylogenetic tree BLASTP predicted a methyltransferase function for ORF 8 and a siliac 
acid synthetase function (neuB family) for ORF 9 (Lüneberg, et al., 2000; Kooistra, et al., 
2002b; Wagner, et al., 2007). 
It is reported that the putative methyltransferase encoded by ORF 8 is responsible 
for N-methylation of the 5-acetimydyol amino group of the legionaminic acid (Kooistra, et 
al., 2002b; Wagner, et al., 2007). This is supported by studies on the legionaminic acid 
pathway of Campylobacter. The ptmH gene (Cj1325) of C. jejuni is a homologue of ORF 8 
of the Knoxville, Camperdown and Heysham subgroup cluster (Figure 5) (McNally, et al., 
2007). The ptmH product catalyzes the modification of CMP-Leg5Am7Ac to the N-
methylated residue CMP-5-acetimidoyl (N-methyl) amino-7-acetamido-3,5,7,9-
tetradeoxynon-2-ulosonic acid (CMP-Leg5AmNMe7Ac), the main residue of the Sg1 
O-antigen. Disruption of ORF 8 in the Bellingham-subgroup strain Görlitz 6543 led to loss-
of-reactivity with the Bellingham-subgroup specific mAb 10/6 and mAb 20/1 and resulted in 
a mAb-subgroup switch from subgroup Bellingham to Camperdown. In similar mutants of 
the mAb 3/1+ strain 130b the reactivity with mAb 20/1 was also lost when ORF 8 or ORF 11 
was disrupted leading to a switch from mAb-subgroup Benidorm to Allentown. The wild type 
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strains 130b and these mutants did not react with mAb 10/6. This supported the assumption 
that the mAb 3/1-specific epitope generated by the O-acetyltransferase Lag-1 masks the N-
methyl group and hinders binding of mAb 10/6 (Wagner, et al., 2007). This is in agreement 
with earlier observations which reported a correlation between ORF 8 and N-methylated 
legionaminic acid residues for the mAb 3/1- strain RC1 (Kooistra, et al., 2002b). However, 
the fact that mutants of both strains, 130b and Görlitz 6543, lost the reactivity with mAb 20/1, 
indicated that ORF 8 and/or ORF 11 are also involved in the generation or modification of 
another epitope which is not blocked by the O-acetyl group. 
To find putative ORF candidates, next to ORF 8, that are responsible for synthesis 
or modification of the common epitope bound by mAb 20/1, we looked for similar but unique 
ORFs within the Sg1-specific region of Bellingham- and Benidorm-subgroup strains. 
Phylogenetic analyses identified ORF 7 as a putative subgroup discriminating gene since 
the mAb-subgroups Benidorm and Bellingham clustered in specific separate group when 
compared to the other mAb-subgroups (Figure 5). The presence of two different ORF 7 
variants is in agreement with recent results obtained by subgroup specific PCR amplification 
(Thürmer, et al., 2009). 
Conclusions 
Characterization of the LPS-biosynthesis loci of L. pneumophila Sg1 strains revealed 
two mayor regions: A Sg1-specific region of 18 kb and a conserved 15 kb region containing 
genes found in Sg1 and non-Sg1 strains. The conserved region carries genes involved in 
outer core and O-chain biosynthesis of LPS molecules. 
The variable and heterogeneous Sg1-specific region raised questions concerning 
the genetic basis for subgroup specific mAb-reactivity. Switches from one monoclonal 
subtype to another in transposon induced mutants gave a first indication for the function of 
different gene products. The most variable region from ORF 6 to ORF 11 is likely involved 
in O-antigen modifications and could deliver more insight in the strain specific LPS 
structures and more important, in strain specific virulence. The ORFs within this region 
could act in a pathway-like manner explaining the broad variability of the LPS molecule 
among the Sg1 strains. Furthermore, it is also not excluded that each ORF of this region 
has an own function in the late modification of legionaminic acid derivates which could be 
regulated in a life cycle or growth phase-depended way. Further studies using specific 
mutation in these ORFs, mRNA assays and chemical analysis are required in order to 
elucidate the role of different genes in the synthesis of the subgroup specific structures in 
different strains. 
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Abstract 
Between 1 August and 6 September 2013, an outbreak of Legionnaires’ disease 
(LD) with 78 cases confirmed by positive urinary antigen tests occurred in Warstein, North 
Rhine-Westphalia, Germany. Legionella (L.) pneumophila, serogroup (Sg) 1, monoclonal 
antibody (mAb) subgroup Knoxville, sequence type (ST) 345, was identified as the epidemic 
strain. This strain was isolated from seven patients. To detect the source of the infection, 
epidemiological typing of clinical and environmental strains was performed in two 
consecutive steps. First, strains were typed by monoclonal antibodies. Indistinguishable 
strains were further subtyped by sequence-based typing (SBT) which is the internationally 
recognized standard method for epidemiological genotyping of L. pneumophila. In an early 
stage of the outbreak investigation, many environmental isolates were found to belong to 
the mAb subgroup Knoxville, but to two different STs, namely to ST345, the epidemic strain, 
and to ST600. A majority of environmental isolates belonged to ST600 whereas the 
epidemic ST345 strain was less common in environmental samples. To rapidly distinguish 
both Knoxville strains, we applied a novel typing method based on DNA-hybridization on 
glass chips. The new assay can easily and rapidly discriminate L. pneumophila Sg1 strains. 
Thus, we were able to quickly identify the sources harboring the epidemic strain, i.e., two 
cooling towers of different companies, the waste water treatment plants (WWTP) of the city 
and one company as well as water samples of the river Wester and its branches. 
Introduction 
Legionellae are ubiquitous gram-negative bacteria, which occupy natural and 
manmade aquatic environments. They are the causative agents of Legionnaires’ disease 
(LD), which occurs mostly as sporadic cases of pneumonia acquired by inhalation or 
aspiration of legionellae from different environmental sources, such as cooling towers, 
whirlpool spas and warm water supplies (Mercante and Winchell, 2015). Currently, the 
genus Legionella comprises 58 species and more than 70 serogroups with Legionella (L.) 
pneumophila serogroup (Sg) 1 causing the majority of human infections (Helbig, et al., 
2002; Harrison, et al., 2009; Parte and Euzéby, 2017). In general, Legionella spp. are 
responsible for 2-20 % of community acquired pneumonia cases (CAP) (Torres, et al., 
2014). Approximately 10 % of cases occur in outbreaks or clusters (European Centre for 
Disease Prevention and Control, 2015b). Legionella outbreaks may present a serious threat 
to public health; and management of outbreaks can be extremely difficult especially if the 
source of infection is unknown (McAdam, et al., 2014).  
Epidemiological typing, i.e., comparison of clinical and environmental isolates of 
L. pneumophila, is mandatory to identify the source of an outbreak (von Baum, et al., 2010). 
Usually, this is performed in two consecutive steps. First, isolates are typed by monoclonal 
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antibodies (mAb) (Helbig, et al., 2002). Indistinguishable isolates are further genotyped by 
sequence-based typing (SBT) which is the internationally recognized standard method for 
epidemiological genotyping of L. pneumophila. This is performed by partial sequencing of 
seven genes and comparison of these alleles to a database to assign a sequence type (ST) 
(ESGLI, 2015).  
Isolates reacting with the mAb 3/1 belong to the subgroups of L. pneumophila strains 
causing the majority of community acquired and travel associated cases (Lück, 2011) as 
well as all cooling tower associated outbreaks yet observed (Walser, et al., 2014).  
The epidemic strain of the outbreak in Warstein was characterized as 
L. pneumophila Sg1, mAb subgroup Knoxville ST345, which was isolated from seven 
clinical samples. However, even knowing the epidemic strain, the identification of the source 
proved to be difficult since the majority of environmental samples yielded enormous 
L. pneumophila counts and multiple different L. pneumophila Sgs, mAb subgroups and STs. 
SBT was not practical and next-generation sequencing was not possible given the high 
number of samples and isolates, the limited resources and the urgency in investigating a 
large-scale and high-profile outbreak. Therefore, we used a L. pneumophila Sg1-specific 
DNA-microarray as a fast and discriminatory tool to investigate outbreak isolates.  
Materials and Methods 
Patient samples investigated during the outbreak  
Between 1 August and 6 September 2013 an outbreak of LD with 78 laboratory 
confirmed cases occurred in the town of Warstein, North Rhine-Westphalia, Germany. All 
these patients had at least one positive urine sample tested with the Binax ELISA (Alere, 
Cologne, Germany). During this outbreak, respiratory specimens from ten patients were 
obtained and cultured on buffered charcoal yeast extract (BCYE) and BCYE agar plates 
supplemented with cefamandole (4 mg/l), polymyxin B (80.000 IU/l) and anisomyxin 
(80 mg/l; BMPA medium; Oxoid, Wesel, Germany) at 1:10 and 1:100 dilutions with and 
without heat pretreatment (3 min at 60 °C) for up to ten days at 37 °C at 5 % CO2 
atmosphere. Eight Legionella isolates could be obtained from seven patients. Isolates were 
initially serotyped using a latex agglutination test (Oxoid) and further subtyped using the 
‘Dresden panel’ of mAbs (Helbig, et al., 2002). Genotyping was performed according to the 
SBT method (ESGLI, 2015). Respiratory samples from three culture-negative samples were 
investigated using the L. pneumophila serogroup 1-specific PCR (Mérault, et al., 2011) and 
the direct nested SBT scheme (Mentasti, et al., 2014). 
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Environmental isolates obtained during the outbreak  
A variety of environmental samples were taken in order to identify the source of the 
outbreak. Those included a cooling tower (CT) from a company (source A), another CT and 
an industrial sewage pretreatment plant (source B), the municipal water supply system and 
the municipal waste water treatment plant (WWTP) (source C), as well as the river Wester 
and its branches (source D). In total, 880 environmental samples were initially cultured and 
screened for the presence of Legionella spp. by the Institute of Hygiene and Public Health 
at the University of Bonn according to ISO 11731/1998 (ISO 11731, 1998). Legionella-
positive culture plates were immediately sent to the German national reference laboratory 
for Legionella in Dresden for further subtyping as described above.  
L. pneumophila isolates tested to validate the newly developed DNA-
based microarray  
In total, 163 epidemiologically unrelated strains and isolates were tested (Suppl. 
Table 5) including 80 European Legionella (EUL) reference strains used for the validation 
of the SBT scheme (Gaia, et al., 2005; Ratzow, et al., 2007) and isolates from the strain 
collection of the German national reference laboratory for Legionella that were originally 
isolated from patients (n=57) and water systems (n=24). 23 of these strains were related to 
five confirmed case clusters or outbreak situations (Table 4). In addition, strains were 
included for which complete genome sequences are publicly available. These were the Sg1 
strains Philadelphia-1 (GenBank NC_002942.5) (Chien, et al., 2004), Lens (GenBank 
NC_006369.1), Paris (GenBank NC_006368.1) (Cazalet, et al., 2004) and Corby (GenBank 
NC_009494.2) (Glöckner, et al., 2008).  
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DNA Microarray Design  
The primers and probes used in the newly developed DNA-microarray are listed in 
the supplemental table 6 and 7. These sequences were derived from published sequences 
using the Array Design software package (Alere Technologies, Jena, Germany). We used 
variants of 25 different target genes which are part of the LPS-biosynthesis cluster 
(Thürmer, et al., 2009) as well as variable genetic elements absent or present in the 
genomes of L. pneumophila Sg1 strains (Pannier, et al., 2010). Additionally, allelic variants 
of the neuA and the pilE genes were included that also are used in the SBT scheme 
(Ratzow, et al., 2007).  
Based on published sequences of the specific target regions mentioned above and 
on the complete genome sequences of the Sg1 strains Philadelphia-1 (Chien, et al., 2004), 
Lens, Paris (Cazalet, et al., 2004) and Corby (Glöckner, et al., 2008), probes and primers 
were designed. In order to provide comparable binding efficiency, these sequences had to 
be specific for each target, to be free from self-hybridizing sequences, and to have similar 
lengths, GC-contents and melting temperatures. 
Finally, these probe and primer sequences were again verified against the GenBank 
database using BLAST (Camacho, et al., 2009) to exclude false-positive reactions resulting 
from possible cross-hybridizations. The Array Design Software Package (Alere 
Technologies) was used to list all theoretically possible hybridizations of the probes to the 
L. pneumophila genomes, allowing up to five mismatches per probe, although measurable 
signals can only be produced with up to two mismatches. This facilitated a prediction of 
hybridization patterns for the sequenced strains. Finally, 97 probes and a biotin staining 
control were spotted in quadruplicate on arrays that were mounted onto ArrayStrips (Alere 
Technologies) (Suppl. Figure 1). The probes range in length from 22 to 33 nucleotides with 
a median length of 27 nucleotides.  
Hybridization experiments were then carried out in order to optimize the protocol. 
The experimental procedures and data processing were initially evaluated by comparing 
DNA-microarray results of the sequenced L. pneumophila strains Philadelphia-1, Lens, 
Paris and Corby with the in silico predicted reactivities that were based on the published 
genomes of these strains. The assay protocol, especially with regard to hybridization and 
washing temperatures, was modified and optimized stepwise until the experimental results 
for these four strains fully matched the in silico predicted hybridization patterns. The 
resulting protocol and data processing step are described below. 
DNA microarray typing 
L. pneumophila isolates were subcultured and recloned on BCYE agar for 48 h. 
Chromosomal DNA was extracted using the automatic DNA extraction system EZ1 
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(QIAgen, Hilden, Germany) and the DNA concentration was measured for purity using the 
Implen P300 (Implen, Munich, Germany) and GeneQuant™ pro (GE Healthcare, Freiburg, 
Germany). 
A multiplex linear primer elongation with 62 primers was used for targeted 
amplification and dUTP-linked biotin incorporation using the Alere HybridizationPlus Kit 
(Alere Technologies). In brief, 1 µg bacterial DNA was added to a master mix containing 
3.9 µl labeling buffer (B1), 0.1 µl DNA polymerase (B2) and 1 µl of the primer mix 
(0.135 μmol/L of each primer). Linear amplification was performed after an initial 
denaturation step (5 min at 96 °C) in 45 cycles of 20 s at 60 °C, 30 s at 72 °C and 20 s at 
96 °C. 
ArrayStrips were read out within 20 min by a reading device (ArrayMate, Alere 
Technologies) according to the manufacturer’s instructions. 
Image analysis  
The raw data of the signal intensity of each spot was normalized as described 
elsewhere (Monecke, et al., 2007; Monecke, et al., 2008). Briefly, the normalized intensity 
(NI) was first calculated, in which NI = 1 – (M / BG), where M is the mean intensity of a spot, 
and BG is the intensity of the local background, giving results between 0 (weak signal, i.e., 
negative) and 1.0 (strong signal, i.e., positive). For further analyses, median values for all 
four spots of one probe were used.  
For the interpretation of normalized data, flexible breakpoints were introduced that 
depended on overall signal quality and staining intensity. An experiment was regarded as 
valid based on the NI median of the biotin staining control and the positive probes that 
recognize the alleles of the gene rnpB (ribonuclease P RNA component). For the calculation 
of the ‘average rnpB & staining control value’ only NI ≥ 0.2 were considered as positive. A 
valid experiment yielded an ‘average rnpB & staining control value’ above 0.666 and has to 
include at least one positive rnpB probe. 
Raw data of each valid experiment were translated in a 97-ternary marker 
hybridization profile (HP) that was composed of ‘positive’ (pos), ‘ambiguous’ (amb) and 
‘negative’ (neg). In valid experiments, the average NIs of a probe that were above 2/3 of the 
‘average rnpB & staining control value’ were regarded positive, all that were above 1/3 but 
below 2/3 of this value were regarded as ambiguous. Signals that were below 1/3 of this 
value were considered negative (Suppl. Table 5). 
Evaluation of microarray performance  
To evaluate the array for reproducibility and stability, 103 strains were tested at least 
twice in independent experiments. Furthermore, sets of related strains were analyzed in 
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order to define a threshold that could assign related isolates to each other based on a HP-
similarity score. Therefore, HPs were compared based on the mapping of categorical data. 
A predefined similarity scoring matrix was used where pos:pos and neg:neg matches were 
assigned as 1 (i.e. 100 % similarity) for self-matches. Matches amb:neg, neg:amb, 
amb:pos, pos:amb were regarded as 0.5, thus having 50 % similarity. Mismatches with 
pos:neg or neg:pos were counted as 0, having no similarity. Based on this matrix a 
dendrogram was calculated using the Unweighted Pair Group Method with Arithmetic mean 
algorithm (UPGMA) of the BioNumerics 7.5 software (Applied Maths, Sint-Martens-Latem, 
Belgium).  
Results  
The detection of the epidemic strain, typed as L. pneumophila Sg1, mAb subgroup 
Knoxville ST345, proved to be difficult due to the high number of other Legionella spp. that 
were present in the environmental samples. For instance, among the first randomly picked 
34 colonies from environmental samples, only four were characterized as the epidemic 
strain using the standardized mAb subgrouping and SBT (Figure 6). A major obstacle for 
the investigation was a simultaneous and abundant presence of a second L. pneumophila 
isolate with the same mAb subgroup Knoxville but with another sequence type - ST600, a 
double locus variant of ST345. When processing the following samples, we put more 
attention on the colony morphology in order to increase our detection rate but colonies of 
Figure 6: Different L. pneumophila Sgs isolated in different sources. After identification of small numbers 
of the epidemic strain only among randomly picked colonies from sources indicated with asterisk (*), we tried to 
focus on the colony shape and increased the detection rate. Source A: pipeline production site; source B: private 
brewery; source C: municipal WWTP; source D: the river Wester with its branches. 
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the prominent ST600 strain could not be distinguished visually with certainty from the 
epidemic strain ST345. 
By using the DNA microarray it was possible to discern the epidemic ST345 isolates 
from the background Knoxville ST600 isolates. Hybridization profiles of the first fully SBT 
genotyped isolates showed that the epidemic strains and the background isolates clearly 
differed from each. Both STs grouped into separate clusters with a HP-similarity score of 
around 90 % (Figure 7). Concurrently, we observed intra-cluster HP-similarity scores 
> 96 % for ST345 isolates and > 94 % for ST600 isolates, respectively (Figure 8). With this 
fast and discriminatory method in hand, it was possible to characterize all L. pneumophila 
Sg1 isolates found during the ongoing Warstein outbreak investigation. In total, 66 
environmental isolates were analyzed. Thirty-one of these formed a separate cluster and 
matched with HP-similarity scores > 96 % to the clinical isolates of the epidemic strain. 
Further 35 isolates could be assigned to the ST600 cluster with a HP-similarity score > 94 % 
(Figure 8). The similarity between the two clusters remained at 90 % after all isolates were 
analyzed. Subsequently, isolates were confirmed as the epidemic strain or ST600 by SBT.  
 
 
Figure 7: Two DNA microarray pictures. Positive hybridization is indicated by grey/black spots. The upper 
array shows a representative isolate of the epidemic strain ST345 (L13-438). The array below represents a 
ST600 background isolate (here W13-845-09). Similarity is based on normalized hybridization profiles (HP) 
and calculated using the Unweighted Pair Group Method with Arithmetic mean algorithm (UPGMA). Position 
of probes can be compared with the s scheme of the array (Suppl. Figure 1). 
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Figure 8: Dendrogram of hybridization profiles (HP). In total 106 selected L. pneumophila Sg1 isolates 
were included. Sequence type and mAb subgroup are indicated. Epidemiological related strains are 
summarized in seven sets (Set A-G) (Table 4). Unrelated clinical (clin) and environmental (env) isolates are 
designated including the sample sites during the outbreak (source A-D). The dashed line indicates a cut-off 
value at the HP-similarity score of 94 %. The dendrogram is calculated using the Unweighted Pair Group 
Method with Arithmetic mean algorithm (UPGMA). 
sim ilarity [%]
st rain-ID m Ab-subgroup ST so u rce ep id. related
W13-959-4 1 Knox 345 env - B Set A
W13-883-1 1 Knox 345 env - D Set A
W13-882-2 1 Knox 345 env - D Set A
W13-873-1 1 Knox 345 env - A Set A
W13-845-4 1 Knox 345 env - A Set A
L13-439 1 Knox 345 clin Set A
W13-954-3 1 Knox 345 env - B Set A
W13-888-1 1 Knox 345 env - D Set A
W13-886-1 1 Knox 345 env - D Set A
W13-885-1 1 Knox 345 env - D Set A
W13-884-2 1 Knox 345 env - D Set A
W13-967 1 Knox 345 env - B Set A
W13-957-3 1 Knox 345 env - B Set A
W13-957-2 1 Knox 345 env - B Set A
W13-953-4 1 Knox 345 env - B Set A
W13-953-3 1 Knox 345 env - B Set A
W13-952-4 1 Knox 345 env - B Set A
W13-881-1 1 Knox 345 env - D Set A
W13-1089-1 1 Knox 345 env - A Set A
L13-435 1 Knox 345 clin Set A
L13-477 1 Knox 345 clin Set A
L13-473 1 Knox 345 clin Set A
L13-446 1 Knox 345 clin Set A
L13-445 1 Knox 345 clin - dupl Set A
L13-444 1 Knox 345 clin Set A
W13-959-3 1 Knox 345 env - C Set A
W13-1096-2 1 Knox 345 env - B Set A
W13-887-1 1 Knox 345 env - D Set A
W13-871-2 1 Knox 345 env - B Set A
W13-875-15 1 Knox 345 env - D Set A
W13-876-13 1 Knox 345 env - C Set A
W13-875-17 1 Knox 345 env - D Set A
W13-875-14 1 Knox 345 env - D Set A
W13-874-15 1 Knox 345 env - A Set A
W13-878-1 1 Knox 345 env - D Set A
W13-871-1 1 Knox 345 env - B Set A
L13-438 1 Knox 345 clin Set A
W13-877-2 1 Knox 345 env - D Set A
W13-879-1 1 Knox 345 env - D Set A
EULV3674 1 Knox 345 clin
EULV4533 1 Knox 345 clin
EULV1647 1 Knox 345 env
Berlin 16 1 Knox 182 clin Set B
Berlin 15 1 Knox 182 clin Set B
Berlin  8 1 Knox 182 clin Set B
Berlin  3 1 Knox 182 clin Set B
Berlin 10 1 Knox 182 clin Set B
Berlin  6 1 Knox 182 clin Set B
W13-845-31 1 Knox 600 env - A Set C
W13-872-2 1 Knox 600 env - D Set C
W13-845-23 1 Knox 600 env - A Set C
W13-845-9 1 Knox 600 env - A Set C
W13-876-16 1 Knox 600 env - C Set C
W13-874-16 1 Knox 600 env - A Set C
W13-876-15 1 Knox 600 env - C Set C
W13-875-13 1 Knox 600 env - D Set C
W13-875-16 1 Knox 600 env - D Set C
W13-874-13 1 Knox 600 env - A Set C
W13-845-28 1 Knox 600 env - A Set C
W13-880-1 1 Knox 600 env - D Set C
W13-845-22 1 Knox 600 env - A Set C
W13-958-4 1 Knox 600 env - B Set C
W13-845-15 1 Knox 600 env - A Set C
W13-845-14 1 Knox 600 env - A Set C
W13-845-25 1 Knox 600 env - A Set C
W13-845-20 1 Knox 600 env - A Set C
W13-845-11 1 Knox 600 env - A Set C
W13-845-21 1 Knox 600 env - A Set C
W13-845-27 1 Knox 600 env - A Set C
W13-845-8 1 Knox 600 env - A Set C
W13-845-34 1 Knox 600 env - A Set C
W13-845-26 1 Knox 600 env - A Set C
W13-845-12 1 Knox 600 env - A Set C
W13-845-5 1 Knox 600 env - A Set C
W13-845-18 1 Knox 600 env - A Set C
W13-845-19 1 Knox 600 env - A Set C
W13-876-18 1 Knox 600 env - C Set C
W13-876-17 1 Knox 600 env - C Set C
W13-876-14 1 Knox 600 env - C Set C
W13-875-18 1 Knox 600 env - D Set C
W13-874-18 1 Knox 600 env - A Set C
W13-874-17 1 Knox 600 env - A Set C
W13-874-14 1 Knox 600 env - A Set C
EULV9125 1 Knox 345 clin
Corby c 1 Knox 51 clin
W10-081 1 Knox 62 env Set E
W10-080 1 Knox 62 env Set E
W10-078 1 Knox 62 env Set E
L10-040 1 Knox 62 clin Set E
L10-023 1 Knox 62 clin Set E
W10-079 1 Knox 62 env Set E
L10-034 1 Knox 62 clin Set E
L08-529 1 Phil 332 clin Set F
W08-1014 1 Phil 332 env Set F
W08-1016 1 Phil 332 env Set F
L08-336 1 Knox 35 clin Set G
L03-525 1 Knox 35 clin Set G
W08-527-2 1 Knox 35 env Set G
W08-526-1 1 Knox 35 env Set G
L12-360 1 Alle Fran 82 clin Set D
W12-948 1 Alle Fran 82 env Set D
L12-384 1 Alle Fran 82 clin Set D
Paris 1 Phil 1 clin
Philadelphia-1               1 Phil 36 clin
Wadsworth 130            1 Beni 42 clin
Lens 1 Beni 15 clin
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The epidemic strain was isolated from samples of two cooling towers of different 
companies (source A and B), the sewage pretreatment plant (source B), the municipal water 
supply system and WWTP (source C), as well as the water samples of the river Wester and 
its branches (source D) (Figure 6 and Figure 8).  
To verify HP-similarity scores we validated the DNA-microarray by using five sets of 
related isolates and several unrelated isolates. Each set of epidemiological related isolates 
formed clusters with a HP-similarity score ≥ 94 %, as seen for the epidemic strain ST345 
and the ST600 outgroup isolates of the Warstein outbreak. The reference value of a HP-
similarity score ≥ 94 % was also seen for 103 unrelated strains that were tested at least 
twice. Valid experiments of repeatedly tested strains never showed HP-similarity scores 
below this threshold. We therefore regarded an HP-similarity score of 94 % and higher as 
good indication to define isolates as related to each when typed during an outbreak 
scenario, thus putatively belonging, i.e., to the same clone. 
Whether the cluster formed by the epidemic strain was unique or a ST345 specific 
cluster was further verified by testing unrelated L. pneumophila ST345 isolates of the mAb 
subgroup Knoxville from Belgium (EULV4533), France (EULV9125) and the Netherlands 
(EULV1647, EULV3674). The three Belgian and Dutch isolates were the closest isolates to 
the ST345 isolates with 90 % (EULV4533), 92 % (EULV1647) and 94 % similarity, 
respectively. One French isolate (EUL4533) had similarities of 85 % (Figure 8) to both 
clusters.  
Discussion 
In August 2013, the town of Warstein faced the largest outbreak of LD ever reported 
in Germany with 78 laboratory-confirmed cases, including two fatalities (Maisa, et al., 2015). 
The significant number of confirmed cases during the outbreak required an investigation for 
possible environmental sources by detailed and intensive sampling of all kinds of water 
reservoirs, including cooling towers, municipal and industrial sewage and WWTPs, 
municipal tap water and river water.  
There are two major tasks for the field investigation team. First, confirm that the 
patients were infected with the same strain, the outbreak strain. Accidental clusters caused 
by different strains have occasionally been detected (Pereira, et al., 2006). The choice of 
diagnostic tools plays thereby an important role to avoid pseudoepidemics due to false-
positive results (Rota, et al., 2014). On the other side long-lasting outbreaks could be 
detected by appropriate diagnostic assays (Scaturro, et al., 2015). Second, the highest 
resolution possible to detect the source of the infection by comparing clinical isolates with 
environmental isolates should be used.  
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Clinical as well as environmental isolates of L. pneumophila Sg1 were analyzed 
using the novel DNA microarray. We found an excellent reproducibility of the hybridization 
signals obtained with the same strains from the ESGLI strain collection (EUL strains) in 
independent experiments. Furthermore, the experimental results for strains with published 
genome sequences showed the expected results.  
The results obtained by the DNA-microarray could be confirmed by established 
typing methods, e.g. mAb subgrouping and SBT (Helbig, et al., 2002; Gaia, et al., 2005; 
Ratzow, et al., 2007). Thus, the microarray succeeded in assigning isolates to the epidemic 
strain of the Warstein outbreak. This supports the application of the microarray during the 
outbreak investigation as a fast and reliable genotyping tool. Using the DNA microarray 
enabled us to rapidly genotype several environmental isolates and hence to identify 
potential sources. 
Due to the fact that several sources harbored the epidemic strain we cannot say with 
certainty whether one or more sources were the origin of infection during the outbreak. On 
the other side it was extremely helpful to implement control methods for the reservoirs where 
we found the epidemic strain. 
The DNA-microarray could be used as surveillance and subtyping tool for 
L. pneumophila Sg1 isolates and it proved to be valuable in the current situation of a 
simultaneous presence of epidemic and environmental strains that yielded the same mAb 
subgroup. However, prior to routine use (as opposed to an emergency use as in the 
discussed outbreak), its discriminatory power must be evaluated based on a larger and 
more diverse panel. 
Conclusion 
Legionella is a frequent cause of bacterial pneumonia in the world. In the event of 
an outbreak a quick and appropriate response is necessary to prevent further cases. 
Microbiological diagnostic tools and subtyping techniques to detect the source of infection 
in a timely manner are indispensable. The newly developed microarray is a promising tool 
for epidemiological investigations comprising the ability to discriminate successfully 
between L. pneumophila Sg1 strains in a rapid and robust manner. 
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Part II - Comment 
The work summarized in Part II focuses on the establishment and validation of a 
novel DNA-DNA hybridization based microarray for the genotyping of L. pneumophila Sg1 
strains. Therefore, a variety of genetic targets were extracted from published 
L. pneumophila genomes by the colleagues from Alere™. Furthermore, the LPS 
biosynthesis loci was analysed in detail to define DNA-probes that distinguish 
L. pneumophila isolates into clonal groups and/or clonal complexes. The DNA-microarray 
runs on a robust and user-friendly platform that was invented by the team at Alere™. It 
eliminates excessive hands-on time and has a higher level of discrimination in comparison 
to the current gold standard methods, such as SBT and mAb-subgrouping.  
Ideally, this DNA-microarray would also be able implement current typing methods 
and assigns e.g. it would simultaneously implement a ST (without sequencing) and a mAb-
subgroup (without using mAbs) to an analysed strain. However, it is evident that transferring 
the complete set of alleles of more than 2,400 STs (SBT Database, acc: 08/2017) to the 
microarray platform is not feasible. In anticipation of the preliminary results, it appears that 
the clustering of clonal groups based on hybridization patterns does not support ST-specific 
clustering. By contrast, the implementation of DNA-probes that differentiate strains into 
mAb-subgroups appears realistic as only nine mAb-subgroups for L. pneumophila Sg1 
strains are described. However, this requires detailed information on the genetic 
background of the differentiation of L. pneumophila isolates into Sgs and subsequently into 
Sg1-specific mAb-subgroups – a research topic that is largely unknown. 
Several studies have suggested the LPS-biosynthesis locus as the main genomic 
region within the genome that is responsible for Sg-specific LPS modifications (Lüneberg, 
et al., 2000). A highly conserved part within this locus, spanning ORF 14 to ORF 28, can be 
found within the genomes of all Sgs. This is thought to be involved in early steps of the 
biosynthesis of legionaminic acid, the main component of the distal O-specific chain 
(McNally, et al., 2006; Schoenhofen, et al., 2006; Glaze, et al., 2008). By contrast, a 
heterogenetic region (ORF 1-ORF 13) is exclusively found in Sg1 strains and is putatively 
transferred via genomic recombination and/or homologous gene transfer. Furthermore, it 
has been demonstrated that differences within this region have an impact on the LPS 
structure, leading to a loss-of-reactivity with LPS-specific mAbs and subsequently resulting 
in mAb-subgroup switches (Zou, et al., 1999; Bernander, et al., 2003; Wagner, et al., 2007). 
Therefore, it can be assumed that this heterogenic region is involved in specific 
modifications of the LPS structure, to be more precisely the legionaminic acid of the O-
chain, of L. pneumophila Sg1 strains (Helbig, et al., 1995; Zähringer, et al., 1995; Knirel, et 
al., 1996; Kooistra, et al., 2001; Lüneberg, et al., 2001; Kooistra, et al., 2002a; Kooistra, et 
al., 2002b; Mérault, et al., 2011).  
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The detailed analysis of the LPS-biosynthesis locus of all the L. pneumophila Sg1 
mAb-subgroups in this work revealed several genes/ORFs that may be involved in mAb-
subgroup specific LPS modifications. These candidates exhibited conserved regions within 
a certain mAb-subgroup and variabilities to all other mAb-subgroups. A total of five genes 
with 37 variants were included in the DNA-microarray’s set of genetic targets, which 
putatively divides L. pneumophila Sg1 isolates into mAb-subgroups according to a 
genotypic approach.  
The overall discriminatory potential of the DNA-microarray was evaluated using 550 
clinical and environmental isolates (Suppl. Table 8). All the strains were typed by using the 
DNA-microarray, SBT and mAb-subgrouping. The hybridization profiles (HP) generated by 
the DNA-microarray were combined to HP-patterns. Hybridization patterns with similarities 
of 90 % and more were bundled into one HP-pattern. In this way, the strains were 
distinguished into 153 HP-patterns. The index of discriminatory power was 0.975 (95 % 
confidence interval [CI]: 0.971-0.981), which was higher than the mAb-subgrouping (IOD: 
0.829; CI 95 % 0.818-0.839), SBT (IOD: 0.947; CI 95 % 0.935-0.958) and both methods 
combined (IOD 0.971; CI 95 % 0.965-0.977) (Hunter and Gaston, 1988; Gaia, et al., 2005; 
Ratzow, et al., 2007).  
Moreover, by extracting the hybridisation results of the selected probes that 
specifically hybridise to LPS-biosynthesis genes, it was possible to construct a typing 
scheme similar to the mAb-subgrouping ‘Dresden panel + mAb3’ scheme (Figure 9). The 
lag-1 gene can achieve a first essential discrimination between isolates. The positive 
hybridization results separate the isolates into the ‘Pontiac group’ and the ‘non-Pontiac 
Benidorm
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Allentown
PhiladelphiaKnoxville
LPS 11 HWPL
LPS 7-1
LPS 7-5
lag-1
+    │    -
Heysham BellinghamOxfordOLDA Camperdown
Pontiac group non-Pontiac group
corresponding
mAb-subgroup
LPS 11 HWPL 
LPS 7-3
LPS 7-8
LPS 8
LPS10
LPS 7-2
LPS 7-4
(3 out of 4)
LPS 7-1
LPS 7-5
and/or
LPS 11 CA
LPS 11 CA
LPS HWPL
LPS 7-3
and/or
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Figure 9: DNA-microarray based mAb-subgrouping.  A classification into the corresponding mAb-subgroup 
is possible on the basis of on the reactivity with LPS biosynthesis genes on the DNA-microarray. The lag-1 
probes divide isolates into the ‘Pontiac group’ and the ‘non-Pontiac group’.  
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group’, in a similar way to the mAb 3/1 [compare Figure 2]. Furthermore, the reactivity of 
the isolate’s DNA with certain mAb-subgroup specific probes assigns a strain according to 
the phenotypic mAb-subgroup. In this way, the mAb-subgroups Knoxville, Benidorm, OLDA 
and Bellingham could be classified. Limitations were observed for the mAb-subgroups 
Philadelphia and France/Allentown and for Oxford, Camperdown and Heysham that could 
not be distinguished.  
The application of the DNA-microarray becomes essential when the isolates of 
certain endemic clones cannot be distinguished by other methods. These clones are 
disproportionally found in specific regions and/or sample types. It I is impossible for SBT 
and mAb-subgrouping to distinguish the isolates of these clones from each other. A 
prominent example is represented by the L. pneumophila isolates, which are typed as mAb-
subgroup OLDA, ST1. Isolates with these characteristics can be found in several 
environmental samples, making it difficult to rely on the results when environmental and 
clinical isolates are compared. However, this dilemma is partially solved by the DNA-
microarray. The group of L. pneumophila mAb-subgroup OLDA ST1 isolates can be further 
divided into smaller clusters. This enabled for instance the identification of the infectious 
source of contamination in a fatal LD case of a new-born in which the environmental and 
clinical isolates shared more that 98 % HP-similarity (Figure 10).  
This indicates that the DNA-microarray allows a fast and reliable genotyping of 
L. pneumophila Sg1 isolates. It proved to be an important tool during the LD outbreak in 
Warstein in 2013, when sample volumes increased enormously and typing results were 
required immediately. A central advantage of the DNA-microarray over the SBT and the 
mAb-subgrouping is its greater discriminatory power, which is based on the HP-patterns. It 
enables endemic clones to be distinguished when current methods fail. Importantly, the 
robust HP-patterns allow a global comparison of isolates, independent of the user, due to a 
transferrable platform. The detailed analysis of the LPS-biosynthesis loci revealed specific 
gene targets that allow the transfer of the mAb-based subgrouping scheme to a genotypic 
approach. Whether certain STs can be subdivided by the DNA-microarray requires further 
evaluation. However, an initial analysis has already revealed that a division into ST-specific 
patterns has proved to be difficult due to the strong heterogeneity within several STs.  
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Figure 10: Dendrogram of hybridization profiles of ST1, mAb-subgroup OLDA isolates.  
Highlighted isolates represent a single case of two clinical isolates L15-129-3, -4 and an 
environmental isolate W15-823-. 1 of the household water system. The dendrogram is calculated 
using the Unweighted Pair Group Method with Arithmetic mean algorithm (UPGMA). [results 
presented at GNPI/DGPI in Dresden 2017; see Publication record]. 
strain       mAb-sbugroup   ST 
   
0
L16-659
W11-039
W10-301
W11-035
L10-495
L13-236
W10-921
Charite 16297/2000
Berlin  4
L00-549
L09-487
W08-696
W09-885-1
W09-901-1
EUL 119
L08-198
L08-334
L13-440
L03-636
L10-197
W10-696?
W10-300
W14-997-1
LG09064011
L16-342
WL16-343-1
L16-262
L10-163
W13-255
WL16-343-2
WL16-343-3
WL16-291-1
W10-261
W10-241
W13-870-2
L05-399
EUL 067                      
WL16-295-2
WL16-294-2
Wien 47-14
L15-123
L15-129-3
L15-129-4
W15-823-1
W17-019
W17-059
W10-053
Goettingen 12/98
L10-226
L10-296
EUL 082                      
EUL 088                      
EUL 085                      
EUL 084                      
EUL 088a
EUL 093                      
W10-201
W10-069
W10-039
W10-423
W15-820
W15-818-1
L10-238
L10-232
W10-604
WL16-688-2
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1 OLDA
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
   
024681012141618202224
 
  
 
                       
 
 
                       
                       
                       
                       
 
                       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Part III - Chapter I 
 
 
Confirming Legionnaires’ Disease Outbreak by 
Genome-Based Method, Germany, 2012 
 
Florian Burckhardt 
Andre Brion 
Jeanette Lahm 
Heinz-Ulrich Koch 
Karola Prior 
Markus Petzold 
Dag Harmsen 
Christian Lück 
 
 
 
 
 
 
 
 
 
Emerging Infectious Diseases 
Bruckhardt et al: Confirming Legionnaires’ Disease Outbreak by Genome-Based 
Method, Germany 2012. EID 2016;22(7):1303-1304 
Submitted 20 October 2015 │ Accepted 07 April 2016 │ Published 22 December 2016 
  
 Part III - Chapter I  
 
51 
To the Editor  
We report an outbreak of Legionnaires’ disease in southwestern Germany. On July 
31, 2012, the State Health Agency of Rhineland-Palatinate was informed by the local health 
department of the city of Zweibrücken that ten patients tested positive for Legionella 
pneumophila, the bacterium that causes Legionnaires’ disease. The onset of disease for all 
case-patients was from June 26 through July 25, which exceeded the yearly average of one 
to four patients a month. By August 23, we had received notifications of 19 patients with 
pneumonia and notification of 1 patient who did not exhibit pneumonia. We set three 
parameters for reporting a patient as a Legionnaires’ disease case-patient. First, the patient 
had to either live in or have been visiting the city of Zweibrücken in June 2012 before onset 
of disease. Second, the respiratory samples from the patient had to contain L. pneumophila 
or the results of patient’s serogroup 1 urinary antigen test had to be positive for the 
bacterium (ECDC, 2015a). Finally, clinical or radiologic confirmation of the disease was 
required. Of 20 patients who fit the case definition, 14 were male and six were female. Nine 
smoked and 2 were immunocompromised; none died. 
All case-patients were positive for L. pneumophila serogroup 1 urinary antigen. From 
clinical samples of two patients, legionellae were cultured, and the infecting strain was 
confirmed as L. pneumophila serogroup 1, monoclonal subgroup Allentown-France, 
sequence type (ST) 82 (Moran-Gilad, et al., 2015; ESGLI, 2015). Currently, 118 strains of 
this ST are found in the European database for sequence-based typing of L. pneumophila 
(ESGLI, 2015). Most ST82 strains were isolated from clinical samples; thus, this ST appears 
more likely than other strains to infect humans. Further, three respiratory samples from 
case-patients were positive in a PCR for L. pneumophila serogroup 1 but were negative by 
culture (Mérault, et al., 2011). These samples were investigated with the nested sequence-
based typing protocol, which allows typing data to be obtained directly from clinical samples 
(ESGLI, 2015). Of the three samples, two were confirmed as ST82. 
The local health authority did not initially identify likely sources of transmission such 
as cooling towers, public spas, or warm water supply systems in the vicinity of the patients 
(Mercante and Winchell, 2015). Environmental samples were taken from the homes of 15 
of the 20 patients; all samples tested negative for Legionella (ISO 11731, 1998). 
To find the source of the outbreak, we plotted 20 home and seven work addresses 
of patients using Quantum-GIS software and found that 18 addresses were within a 2-km 
radius of each other, including two patients who had limited mobility and had not left their 
homes during their incubation period (Figure 11) (QGIS, 2012). We conducted a site visit 
on August 22 to inspect a sewage plant and 2 large manufacturing plants (A and B) that 
were within the same 2-km radius. Neither the sewage plant nor plant A had a potential 
Legionella source. Plant B had a cooling tower mounted on a rooftop that was described by 
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the company as a closed circuit cooling system, indicating that no aerosols would be 
released, and thus was missed by the initial local health department inquiry. However, 
closed circuit referred only to the primary cooling circuitry, whereas excess heat was 
exchanged through wet surface cooling, allowing release of aerosols into the atmosphere. 
The local health department immediately shut down the cooling tower, and plant B used 
shot-dose chlorine to disinfect it. Before disinfection, we obtained three swab specimens 
and 250-mL samples of water from the reservoir and plated them in dilutions with and 
without acid wash (ISO 11731, 1998; ISO 11731-2, 2008). Samples without acid wash were 
completely overgrown, whereas a single 1-mL sample with acid wash showed 20 Legionella 
colonies after seven days. Three colonies were typed and found to belong to the epidemic 
strain. Of the 27 work and home addresses, six were within a 1-km radius of the cooling 
tower, and 18 were within a 4-km radius (Figure 11). No further cases occurred within the 
incubation period (up to 14 days after closure of the cooling tower). 
Figure 11: Geographic distribution of cooling tower and home and work addresses (n = 23) of patients. 
One patient may be represented twice with home and work address, because place of infection is unknown. 
The addresses marked “immobile” belong to 2 patients who had not left their homes. Two samples had 
undergone core genome multilocus sequence typing (cgMLST), and sequence type (ST) 82 was typed 
(represented by 2 home addresses and 1 work address). For 2 samples, only ST82 was typed. Two dots in the 
1-km radius are overlapping each other. Four addresses (9 km, 10 km, 19 km, and 26 km from the cooling 
tower) are outside the scale of the map. Circle radii are from 1 km to 4 km, centered on the cooling tower. 
Shapefiles for mapping by OpenStreetMap contributors. 
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To further confirm this cooling tower as the source of the outbreak, we applied core 
genome multilocus sequence typing (cgMLST) (Moran-Gilad, et al., 2015). We analyzed 
allelic differences of 1,521 gene targets of the core genome of L. pneumophila using the 
pairwise ignore missing values option in SeqSphere+ software (Ridom GmbH, Münster, 
Germany). Results showed that the strains from 2 patients with culture-positive test results 
and the three environmental ST82 strains were identical in their cgMLST profile, which 
covers 47 % of the Philadelphia-1 reference genome. Currently, no German law requires a 
registry for cooling towers; such a registry would accelerate identification of potential 
L. pneumophila emission during outbreaks (Maisa, et al., 2015). In January 2015, a code of 
conduct for maintenance of cooling towers went into effect (VDI, 2015). Modern typing 
methods such as cgMLST can serve as supporting tools in confirming infection origin. 
However, this method must be validated on a larger scale, and its discriminatory power 
compared with that of current typing methods. Further cgMLST studies with other ST82 
strains are underway.  
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Abstract 
Introduction  
Whole genome sequencing (WGS) is increasingly used in Legionnaires’ disease 
(LD) outbreak investigations, owing to its higher resolution than sequence-based typing, the 
gold standard typing method for Legionella pneumophila, in the analysis of endemic strains. 
Recently, a gene-by-gene typing approach based on 1,521 core genes called core genome 
multilocus sequence typing (cgMLST) was described that enables a robust and 
standardised typing of L. pneumophila.  
 
Methods  
We applied this cgMLST scheme to isolates obtained during the largest outbreak of 
LD reported so far in Germany. In this outbreak, the epidemic clone ST345 had been 
isolated from patients and four different environmental sources. In total 42 clinical and 
environmental isolates were retrospectively typed.  
 
Results  
Epidemiologically unrelated ST345 isolates were clearly distinguishable from the 
epidemic clone. Remarkably, epidemic isolates split up into two distinct clusters, ST345-A 
and ST345-B, each respectively containing a mix of clinical and epidemiologically-related 
environmental samples.  
 
Discussion/conclusion  
The outbreak was therefore likely caused by both variants of the single sequence 
type, which pre-existed in the environmental reservoirs. The two clusters differed by 40 
alleles located in two neighbouring genomic regions of ca 42 and 26 kb. Additional analysis 
supported horizontal gene transfer of the two regions as responsible for the difference 
between the variants. Both regions comprise virulence genes and have previously been 
reported to be involved in recombination events. This corroborates the notion that genomic 
outbreak investigations should always take epidemiological information into consideration 
when making inferences. Overall, cgMLST proved helpful in disentangling the complex 
genomic epidemiology of the outbreak. 
 
Introduction 
Legionella spp. is the causative agent of Legionnaires’ disease (LD) named after its 
first occurrence during a convention of the American Legion in 1976 (Fraser, et al., 1977; 
McDade, et al., 1977). These rod shaped Gram-negative bacteria inhabit all kinds of natural 
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and man-made fresh water reservoirs including cooling towers (CT), spas and drinking 
water systems. Inhalation of legionellae-containing aerosols originating from contaminated 
environmental reservoirs is the main route of infection. However, a case of a person-to-
person transmission of Legionella under special circumstances was recently reported 
(Correia, et al., 2016). 
LD accounts for 2–20% of community-acquired pneumonia (CAP) and the number 
of cases in Europe reached almost 6,000 in 2014 (Torres, et al., 2014). In Germany ca 
1,000 cases are reported annually, representing an incidence of ca 11 cases per million 
population (RKI, 2016). In Europe ca 10 % of the cases are related to clusters or outbreaks. 
So far, 60 species and more than 70 serogroups (Sg) of the genus Legionella were reported 
from which around half were implicated in human infections (Bajrai, et al., 2016). The vast 
majority of LD cases is caused by L. pneumophila serogroup Sg1 isolates, especially 
monoclonal antibody (mAb) 2/3–1 positive strains (ECDC, 2015b). Hitherto, all CT-related 
outbreaks reported worldwide were caused by these subtypes (Walser, et al., 2014). 
Molecular and serological typing methods are predominately applied to the species 
L. pneumophila. The two well-established epidemiological typing methods for comparison 
of clinical and environmental isolates consist of the subgrouping scheme based on mAbs 
and the sequence based typing (SBT) method, an adapted multilocus sequence typing 
(MLST) variant that defines sequence types (ST) (Helbig, et al., 2002; ESGLI, 2015). Other 
methods have been described but lack uniform interpretation of results in inter-laboratory 
comparison studies (Van Belkum, et al., 2007; Sabat, et al., 2013). 
Currently, SBT is the gold standard to genotype L. pneumophila isolates. The allelic 
profile of seven genes enables the assignment of an ST to the corresponding isolate. A 
database, curated by Public Health England (PHE), London, United Kingdom, in 
cooperation with the European Centre for Disease Prevention and Control (ECDC), 
Stockholm, Sweden, facilitates the exchange of typing data and can be queried for 
surveillance and epidemiological studies of L. pneumophila (ESGLI, 2015). Currently, the 
database consists of more than 11,000 reported isolates with 2,298 different STs (status as 
of 05 January 2017). Despite the index of discrimination of the SBT scheme being around 
0.92, typing of frequently circulating STs with this method, e.g. ST1, ST47 and ST23, proves 
less informative to further differentiate strains within these rather big clonal groups (David, 
et al., 2016b). An additional typing step is thus needed, but modalities attempted thus far 
such as spoligotyping were of limited value (Ginevra, et al., 2012). 
Due to a higher level of discrimination compared with gold standard typing methods 
of different bacteria, including L. pneumophila, whole genome sequencing (WGS) has 
become a frequently applied tool in outbreak investigations (Reuter, et al., 2013; Graham, 
et al., 2014; Lévesque, et al., 2014; McAdam, et al., 2014; Moran-Gilad, et al., 2015; 
Raphael, et al., 2016). While use of this tool has mostly relied on analysis of single nt 
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polymorphisms (SNPs), a few studies are based on a genome-wide gene-by-gene typing 
approach for L. pneumophila Sg1 strains. These extended MLST schemes enable a 
detailed comparison of two or more isolates by either considering all genes of a species 
(pangenome) in what is called whole genome MLST (wgMLST), or alternatively, a set of 
conserved genes of a species, namely core genome MLST (cgMLST) (Maiden, et al., 2013). 
Analysis of several related strains and strains that were involved in small outbreaks using 
these cgMLST or wgMLST produced results that were in agreement with current standard 
typing methods, indicating the suitability of these methods as typing tools for 
L. pneumophila Sg1 isolates (Moran-Gilad, et al., 2015; Burckhardt, et al., 2016; Raphael, 
et al., 2016). 
Here, we report in detail the retrospective application of a previously described 
cgMLST scheme consisting of 1,521 genes (Moran-Gilad, et al., 2015), to the largest 
outbreak of LD reported so far in Germany, in order to validate this scheme on a large and 
homogenous set of isolates. The outbreak occurred in the summer of 2013 in the city of 
Warstein. In total, 78 confirmed LD cases were reported and multiple potential 
environmental sources of infection carrying the outbreak strain were implicated. These 
included several CTs, municipal and private waste water treatment plants (WWTPs) and 
the river Wester, which runs through the city of Warstein. The outbreak strain was 
characterised as L. pneumophila Sg1, mAb-subgroup Knoxville, ST345 (Maisa, et al., 
2015). 
Methods 
Cultivation of L. pneumophila isolates and DNA extraction 
Respiratory samples (bronchoalveolar lavages, BAL) from outbreak patients, with 
and without heat treatment at 50 °C for 30 min were plated on non-selective buffered 
charcoal-yeast extract (BCYE) agar and a selective agar containing cefamandole, 
polymyxin B, and anisomycin (BMPA) and incubated at 36 °C in humidified atmosphere 
supplemented with 5% CO2. Isolated strains were initially serotyped by using a latex 
agglutination test (Oxoid, Wesel, Germany) and confirmed by using the Dresden panel of 
mAbs as described elsewhere (Helbig, et al., 2002). The environmental isolates were 
isolated according to ISO11731/1998 (Essig, et al., 2016; Petzold, et al., 2016) and typed 
in a similar way. Additionally, all samples were typed according the L. pneumophila SBT 
protocol (ESGLI, 2015). 
DNA from respiratory samples was extracted using the EZ1 DNA tissue kit (Qiagen, 
Hilden, Germany) according to manufacturer instructions. Clinical samples were tested with 
a L. pneumophila specific PCR (DUPLICα RealTime Legionella pneumophila Kit, 
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Euroclone, Milan, Italy) and a L. pneumophila Sg1 specific PCR (Mérault, et al., 2011). 
Furthermore, direct genotyping from three culture negative PCR-positive clinical samples 
was attempted using the nested SBT (nSBT) protocol (Mentasti, et al., 2012). 
Whole genome sequencing and assembly  
Deep frozen clinical and environmental isolates collected during the outbreak (stored 
in 15% glycerol at − 80 °C) were thawed, sub-cultured on BCYE-agar plates (Oxoid, Wesel, 
Germany), and incubated for another 48 hour as described above. We additionally included 
unrelated isolates of ST345 as well as two strains of L. pneumophila Sg1 mAb-subgroup 
Knoxville ST600, a double locus variant of ST345 frequently isolated during the outbreak 
(Table 5). Colonies were harvested and resuspended in sterile distilled water for 
subsequent DNA extraction using the purification protocol for Gram-negative bacteria of the 
MagAttract HMW DNA Kit (Qiagen, Hilden, Germany). 
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C: clinical sample, E: environmental sample, ID: identity, NA: not applicable, ND: not determined, ST: sequence type 
a: source of sample: C corresponds to clinical isolates; E corresponds to environmental isolates 
b: Monoclonal subgrouping as described by Helbig and coworkers (Helbig, et al., 2002)  
c: Sequence based typing by using Sanger sequencing according to the ESCMID Study Group for Legionella Infections 
(ESGLI) protocol (ESGLI, 2015) 
d: Outbreak ST345 strain clone assignment by core genome multiclocus sequences typing  
e: Isolate L13-445/-446 were isolated from the same patient. 
f: The molecular antibody-subgroup and/or sequence type were/was not determined because no isolate was obtained and/or 
because of incomplete direct sequence-based typing. 
g: Clone assignment within the ST345 outbreak strain was not applicable when the isolate was from a chosen non-outbreak 
reference strain, when the isolate had another ST than ST345, or when no isolate could be obtained. 
  
Sample ID / source (C/E)a Epidemiological context to outbreak Culture Monoclonal subgroupb STc
Allelic profile
(flaA, pilE, asd, mip, mompS, proA, neuA)
Outbreak 
cloned
L13–435 (C) Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-B
L13–438 (C) Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-B
L13–439 (C) Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-B
L13–444 (C) Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
L13–445/-446 (C)e Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
L13–473 (C) Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-B
L13–477 (C) Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–845–1 (E) Cooling tower, source A, Warstein outbreak  + Knoxville 600 6, 10, 19, 28, 19, 4, 11 NAf
W13–845–4 (E) Cooling tower, source A, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–845–8 (E) Cooling tower, source A, Warstein outbreak  + Knoxville 600 6, 10, 19, 28, 19, 4, 11 NAf
W13–871–1 (E) Condenser, source B, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–873–1 (E) Pump shaft, source A, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–874–15 (E) Pump shaft, source A, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–875–15 (E) River inlet, source A, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–875–17 (E) River inlet, source A, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–876–13 (E) Aeration basin, source C, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–878–1 (E) River water, source D, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–879–1 (E) River water, source D, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–952–4 (E) Pre-sedimentation basin, source B, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–953–3 (E) Pre-sedimentation basin, source B, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-B
W13–953–4 (E) Pre-sedimentation basin, source B, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-B
W13–954–3 (E) Pre-sedimentation basin, source B, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-B
W13–957–2 (E) Outlet, source B, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–959–3 (E) Aeration basin, source C, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-B
W13–959–4 (E) Inlet from source B, source C, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-B
W13–1093 (E) Cooling tower, source A, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W13–1096–2 (E) Cooling tower, source A, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W14–178 (E) Pre-sedimentation basin, source B, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W14–472 (E) Pre-sedimentation basin, source B, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W14–474 (E) Pre-sedimentation basin, source B, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
W14–476 (E) Pre-sedimentation basin, source B, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-B
W14–489 (E) Pre-sedimentation basin, source B, Warstein outbreak  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 ST345-A
P13–308 (C) Clinical sample, Warstein outbreak - NDf 345 6, 10, 19, 3, 19, 4, 11 NAg
P13–402 (C) Clinical sample, Warstein outbreak - NDf ND 6, 10, 0, 3, 0, 4, 11 NAg
P13–733 (C) Clinical sample, Warstein outbreak - NDf 345 6, 10, 19, 3, 19, 4, 11 NAg
EULV1461 (C) Unrelated isolate (France)  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 NAg
EULV1647 (E) Unrelated isolate (the Netherlands)  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 NAg
EULV1654 (C) Unrelated isolate (the Netherlands)  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 NAg
EULV3674 (C) Unrelated isolate (the Netherlands)  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 NAg
EULV5358 (C) Unrelated isolate (France)  + OLDA 345 6, 10, 19, 3, 19, 4, 11 NAg
EULV6345 (C) Unrelated isolate (France)  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 NAg
EULV9125 (C) Unrelated isolate (France)  + Knoxville 345 6, 10, 19, 3, 19, 4, 11 NAg
Corby (C) Unrelated isolate (United Kingdom)  + Knoxville 51 6, 10, 15, 28, 9, 14, 6 NAg
Alcoy 2300/99 (C) Unrelated isolate (Spain)  + Knoxville 578 6, 10, 15, 13, 9, 14, 6 NAg
Philadelphia-1 Unrelated isolate (United States)  + Philadelphia 36 3, 4, 1, 1, 14, 9, 1 NAg
Table 5: Legionella pneumophila serogroup 1 samples and isolates used for the retrospective analysis 
of a 2013 Legionnaires’ disease outbreak by core genome multilocus sequence typing, Germany 
(n = 46) 
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Sequencing libraries were prepared using the Nextera XT library prep kit (Illumina 
GmbH, Munich, Germany) for a 250 bp paired-end sequencing run on an Illumina MiSeq 
sequencer. Samples were sequenced to aim for a minimum 100-fold coverage using 
Illumina’s recommended standard protocols with dual-index barcoding and rotation of 
barcodes over time. Sequencing run quality (Q30 and output) had to fulfil the manufacturer’s 
minimum specifications. The resulting FASTQ files were quality trimmed and assembled de 
novo using the Velvet assembler that is integrated in Ridom SeqSphere +  v.3.0 software 
(Ridom GmbH, Münster, Germany) (Jünemann, et al., 2013). Here, reads were trimmed at 
their 5'- and 3'-ends until an average base quality of 30 was reached in a window of 20 
bases, and the assembly was performed with Velvet version 1.1.04 (Zerbino and Birney, 
2008) using optimised k-mer size and coverage cut-off values based on the average length 
of contigs with > 1,000 bp. 
Core genome multilocus sequence typing cgMLST analysis 
A cgMLST was performed using SeqSphere +  with the L. pneumophila typing 
scheme described by Moran-Gilad et al. (2015). This scheme includes 1,521 core genome 
genes and the basic local alignment search tool (BLAST)-based allele calling procedure 
details have been described previously (Moran-Gilad, et al., 2015). The percentage of good 
cgMLST targets determined the overall sequence quality of every sample such that samples 
containing at least 95% of extracted cgMLST targets were considered typeable. Alleles for 
each gene were assigned automatically by the SeqSphere +  software to ensure a unique 
nomenclature. The combination of all alleles in each strain formed an allelic profile that was 
used to generate minimum spanning trees (MST). Targets with missing values in one of the 
strains compared were omitted during distance calculation. In order to maintain backwards 
compatibility with L. pneumophila SBT, sequences of the seven genes comprising the allelic 
profile of the SBT schemes were separately extracted from finished genomes and WGS 
data and then queried against the SBT database (ESGLI, 2015) in order to assign classic 
STs in silico. 
Detection of recombined regions 
The de novo assembly FASTA contig files of four samples were chosen (L13–435, 
L13–473, W13–879–1, and W13–952–4) in order to analyse their genomes for putative 
recombined regions. Mauve (version 20150226 build 10, default parameters) (Darling, et 
al., 2010) was used to calculate a multiple alignment of the four genomes. A SeqSphere +  
function was used to convert the Mauve alignment file from XMFA format into a FASTA and 
thereby concatenating the alignments for each of the four sample sequences and replacing 
all ambiguous bases against ‘N’. Gubbins (version 1.4.5, default parameters) (Croucher, et 
 Part III - Chapter II  
 
62 
al., 2015) was used for recombination prediction based on the Mauve alignment. Predicted 
recombined regions (> 7,500 bp) were subsequently scanned with SeqSphere +  against all 
cgMLST targets (using BLAST with thresholds 66% identity and 50% overlap) to reveal 
corresponding targets within the recombined region. 
Data availability 
All raw reads generated were submitted to the European Nt Archive 
(http://www.ebi.ac.uk/ena/) of European molecular biology laboratory (EMBL) European 
Bioinformatics Institute (EBI) under the study accession number PRJEB12633. The 
cgMLST targets as well as the allelic profiles of each isolate were deposited at the 
cgMLST.org nomenclature server (http://www.cgmlst.org). 
Results 
The outbreak occurred in the city of Warstein, Germany, in 2013 and involved 78 
laboratory-confirmed LD cases (Maisa, et al., 2015). Respiratory samples from 10 patients 
tested positive using the L. pneumophila and the Sg1-specific PCRs. From seven of these 
patients, eight clinical isolates were recovered. All these isolates were characterised as 
L. pneumophila Sg1, mAb-subgroup Knoxville, ST345 and regarded as being of the 
particular outbreak strain. This outbreak strain was also isolated from an industrial CT 
(source A; source designation as in (Maisa, et al., 2015), two WWTPs (source B and C) and 
the river Wester (source D) running through the town of Warstein. 
In total, 42 strains were used in cgMLST analysis. These strains comprised the eight 
clinical isolates identified by conventional means as outbreak strain and 25 
epidemiologically related environmental isolates. Furthermore, seven unrelated ST345 
strains (six environmental and one clinical) as well as two reference genomes of the strains 
Corby and Alcoy 2300/99 were also included (Table 5). All seven unrelated ST345 isolates 
that were deposited in the European SBT database for L. pneumophila (ESGLI, 2015) until 
the outbreak occurred were part of those strains. Furthermore, two environmental 
L. pneumophila Sg1 isolates of the same mAb-subgroup Knoxville as the outbreak strain 
but of a different but close genotype, ST600, were analysed. These ST600 isolates were 
found in higher numbers than the epidemic strain in all environmental samples taken during 
the outbreak but were not recovered from any of the clinical samples (Table 5) (Petzold, et 
al., 2016). 
Although the original scheme as described by Moran-Gilad et al. (2015) consists of 
1,521 targets, some targets can happen to be absent in some strains. Therefore, a minimum 
spanning tree (MST) was constructed based on 1,475 targets of the cgMLST scheme that 
were present in all analysed genomes. Remarkably, the MST identified two clearly 
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distinguishable clusters of the ST345 isolates obtained during the outbreak, hereafter 
referred to as ST345-A and ST345-B (Figure 12). 
Figure 12: Analysis by minimum spanning tree based on 1,475 core genome multilocus sequence 
typing targets of isolates recovered in 2013 during a Legionnaires’ disease outbreak, Germany (n = 42 
strains).Numbers on lines represent the allelic differences between the isolates. All but two isolates in the 
Figure are sequence type (ST) 345. The two ST600 isolates are indicated with (§). All ST345 isolates which 
are unrelated to the outbreak and which serve as outgroup belong to the monoclonal antibody (mAb)-
subgroup Knoxville, except EULV5358, which is mAb subgroup OLDA and which is indicated with (*).CT: 
cooling tower; WWTP: waste water treatment plant. 
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Although the original scheme as described by Moran-Gilad and colleagues consists 
of 1,521 targets, it happens that targets are absent in some strains. Therefore, a minimum 
spanning tree (MST) was constructed based on 1,475 targets of the cgMLST scheme that 
were present in all analysed genomes. Remarkably, the MST identified two clearly 
distinguishable clusters of the ST345 isolates obtained during the outbreak, hereafter 
referred to as ST345-A and ST345-B.  
Cluster ST345-A consisted of four clinical isolates (including two isolates from the 
same patient L13–445/-446) and 17 isolates recovered from all four putative environmental 
sources A–D. From these isolates, twelve showed no allelic difference and nine isolates 
differed each in a single allele from this central node. The remaining 10 ST345 outbreak 
isolates grouped as a separate cluster ST345-B, which differed in 39 alleles from ST345-A. 
Nine of the 10 ST345-B isolates showed an identical cgMLST profile and were isolated from 
four clinical and five environmental samples of sources B and C (both WWTPs). One 
environmental sample from source B showed one allele difference. Direct comparison of 
both clusters using all 1,521 cgMLST targets revealed in fact 40 alleles difference. The 
seven unrelated ST345 isolates were quite diverse revealing from 17 allelic differences 
between EULV1647 and EULV1654 up to 1,023 differences between EULV5358 and 
EULV3674. The unrelated ST345 isolate EULV1461 had only 21 allelic differences to the 
epidemic clone ST345-B. The two ST600 isolates showing only one allele difference from 
each other as well as the genomes of Corby and Alcoy 2300/99 clearly differ from the ST345 
clones in more than 800 alleles (Figure 12). 
We further investigated the differences between the two ST345 clusters in more 
detail. The aforementioned 40 different alleles are apparently located on two distinct 
neighbouring genomic regions including respectively 27 targets (recombination region 1; 
corresponding genes of reference strain Philadelphia-1 lpg2604–2636) and 13 targets 
(recombination region 2; lpg2666–2687) (Table 6). 
The affected genes comprise virulence factors including genes of the Dot/Icm Type 
IV secretion system and genes involved in the muramyl synthesis (Ensminger and Isberg, 
2009; Liu, et al., 2012). In addition, a SNP analysis for these regions revealed several SNPs 
ranging from two to > 118 SNPs per gene with an average of two SNPs per 100 bp (Table 
6). To investigate if the two regions resulted from potential large recombination events and 
juxtaposition of the involved genes and regions, the genomes of four isolates were chosen, 
two from each cluster (ST345-A: W13–879–1/W13–952–4; ST345-B: L13–435/L13–473), 
the genomes were multiple aligned with Mauve, and searched for evidence of ‘import’ of 
divergent sequences from a distantly related source using Gubbins. Two large 
recombination regions of ca 42 and 26 kb size were predicted and subsequently screened 
for all cgMLST targets. The scanning procedure resulted exactly in the 27 and 13 cgMLST 
targets that were already detected as potentially recombinatory by SeqSphere +. Finally, the 
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40 targets were compared against published genomes, thereby revealing that the ST345-A 
cluster differed from the ST36 strain Philadelphia-1 only in three of these (Table 6). 
Table 6: Core genome multilocus sequence typing targets differing between the two ST345 outbreak 
variants identified in a 2013 Legionnaires’ disease outbreak, Germany 
 
cgMLST: core genome multilocus sequence typing, ID: identity, SNP: single nt polymorphism, NA: not applicable  
a: Reference genome L. pneumophila strain Philadelphia-1; GenBank accession number NC_002942.5; cgMLST allele 
number for each target: “1” 
b: There is currently no assigned name for this gene 
 
Discussion 
Here we present the results of the analysis of L. pneumophila ST345 strains isolated 
during the outbreak of Warstein 2013 (Maisa, et al., 2015) using a recently published 
cgMLST scheme. While less than 10% of reported LD cases occur in clusters and outbreaks 
(Mercante and Winchell, 2015), each outbreak must be regarded as a serious threat for 
public health since LD is a potentially life-threatening disease with case fatality rate of ca 
10% (Phin, et al., 2014). Since the clinical picture of LD is not specific, the diagnosis always 
requires laboratory investigation. Of 78 epidemiologically and laboratory-confirmed cases 
of this large outbreak we were able to isolate the epidemic strain from seven patients. In 
Targeta Begin End Gene name GenBank protein_ID
cgMLST allele number
ST345-A
cgMLST allele number
ST345-B
SNPs per target
Differing cgMLST targets in 42 kb recombination region (27 targets)
lpg2604 2938631 2939434 NAb YP_096609.1 1 4 11
lpg2606 2940021 2940887 NAb YP_096611.1 1 4 5
lpg2607 2941026 2943062 pepO YP_096612.1 1 4 21
lpg2608 2943206 2944120 lpxC YP_096613.1 1 2 9
lpg2609 2944368 2945564 ftsZ YP_096614.1 1 4 12
lpg2610 2945759 2947021 ftsA YP_096615.1 1 4 26
lpg2612 2947732 2948838 ddl YP_096617.1 1 4 16
lpg2614 2949745 2951154 murC YP_096619.1 1 4 17
lpg2615 2951164 2952348 ftsW YP_096620.1 3 5 14
lpg2616 2952345 2953688 murD YP_096621.1 1 4 9
lpg2617 2953702 2954820 mraY YP_096622.1 1 4 7
lpg2618 2954902 2956287 murF YP_096623.1 1 4 13
lpg2619 2956480 2957259 NAb YP_096624.1 1 4 7
lpg2620 2957264 2960758 NAb YP_096625.1 1 5 63
lpg2621 2960933 2961613 NAb YP_096626.1 1 4 9
lpg2622 2961715 2962776 NAb YP_096627.1 1 4 13
lpg2623 2963086 2963898 NAb YP_096628.1 1 4 12
lpg2624 2963973 2964455 greA YP_096629.1 1 4 10
lpg2625 2964464 2967667 carB YP_096630.1 1 4 77
lpg2626 2967794 2968066 NAb YP_096631.1 1 4 22
lpg2627 2968179 2969360 NAb YP_096632.1 1 4 85
lpg2629 2970147 2971217 NAb YP_096634.1 1 4 13
lpg2630 2971214 2972215 NAb YP_096635.1 1 4 15
lpg2631 2972463 2973947 pepA YP_096636.1 1 4 25
lpg2633 2974501 2974818 NAb YP_096638.1 3 5 5
lpg2635 2976210 2977781 mviN YP_096640.1 1 4 26
lpg2636 2978139 2978405 rpsT YP_096641.1 1 2 2
Differing cgMLST targets of 26 kb recombination region (13 targets)
lpg2666 3013221 3014102 NAb YP_096671.1 1 4 9
lpg2667 3014236 3015114 rpoH YP_096672.1 1 4 5
lpg2668 3015387 3016316 ftsX YP_096673.1 1 4 15
lpg2671 3018077 3019402 NAb YP_096676.1 1 4 17
lpg2672 3019399 3020703 NAb YP_096677.1 1 4 25
lpg2673 3020700 3021245 NAb YP_096678.1 1 4 10
lpg2676 3022673 3023836 dotB YP_096681.1 1 4 21
lpg2678 3025688 3026485 NAb YP_096683.1 1 4 4
lpg2679 3026515 3027459 NAb YP_096684.1 1 4 17
lpg2680 3027690 3028718 murE3 YP_096685.1 1 4 27
lpg2683 3030713 3032560 NAb YP_096688.1 1 4 118
lpg2684 3032560 3033420 NAb YP_096689.1 3 5 35
lpg2687 3037576 3038031 icmV YP_096692.1 1 4 34
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three additional clinical samples that were culture-negative, nSBT allowed the complete ST 
in two (P13–308 and P13–733, Table 5), and a nearly complete allelic profile in the third 
(P13–402). Thus, we could detect the epidemic strain in samples of 10 patients (Table 5). 
The rate of complete or almost complete identified STs (10/78; 12%) is in the range as 
reported from other outbreaks (Lévesque, et al., 2014; McAdam, et al., 2014; Sánchez-
Busó, et al., 2016). However, there is a need to improve the recovery of clinical isolates in 
general in order to assign patients properly to an outbreak. 
In the last 5 years, Legionnaires’ disease outbreak investigations have increasingly 
included WGS (Reuter, et al., 2013; Graham, et al., 2014; Lévesque, et al., 2014; McAdam, 
et al., 2014; Raphael, et al., 2016). The main approach has been SNP-based, by mapping 
reads of clinical and environmental strains against a known reference genome. Although 
this enables precise differentiation between outbreak and non-outbreak isolates, the use of 
different reference genomes and mapping approaches makes SNP-based typing difficult to 
standardise. With the standardised generation, analysis and interpretation of WGS data and 
the establishment of a comprehensive bioinformatics pipeline and nomenclature, cgMLST 
allows to overcome this obstacle (Moran-Gilad, et al., 2015; Raphael, et al., 2016).  
In this study, the application of cgMLST to a Legionnaires’ disease outbreak revealed 
two distinct clusters of the epidemic L. pneumophila clone, namely ST345-A and ST345-B, 
differing in 40 alleles. This difference clearly exceeds the preliminary threshold for a WGS 
cluster of four alleles difference, as shown previously (Moran-Gilad, et al., 2015; Burckhardt, 
et al., 2016). Both clusters were indistinguishable by common gold standard methods and 
other typing methods (Petzold, et al., 2016). Since strains in both clusters of the epidemic 
clone were almost equally distributed among clinical samples and epidemiologically linked 
to environmental strains by place and time of occurrence, we assume that this outbreak 
was caused by a single epidemic ST with two variants, which were already present in the 
environmental reservoirs before the outbreak occurred.  
Since the WGS analysis demonstrated a notable distance between the outbreak 
clusters, we closely examined the arrangement of the differing alleles. This analysis 
suggested that two major recombination events, most probably by horizontal gene transfer 
(HGT), may explain the differences between the two variants. Interestingly, the regions 
involved (42 and 26 kb) have already been reported as involved in a recombination event 
in a Spanish endemic clone of the same mAb-subgroup Knoxville (Sánchez-Busó, et al., 
2014). The results of our investigation should serve as a note of caution for the use of WGS 
in outbreak investigations. Although gene-by-gene allele calling procedures like cgMLST 
inherently mitigate, in contrast to SNP calling procedures, against the effects of smaller 
recombination events, the method is prone to effects of large recombination events. 
Therefore, epidemiological information and/or compensation for recombination with 
methods as implemented in Gubbins or BratNextGen (Marttinen, et al., 2012) are strongly 
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recommended and, ideally, could be implemented in WGS-based typing and cgMLST 
standardised workflows. 
An intriguing aspect would be the identification of the potential donor of the HGT 
regions. Comparison of the recombined regions with published genomes revealed a high 
similarity of the ST345-A variant to the L. pneumophila strain Philadelphia-1 (ST36), which 
was the causative agent of the first described outbreak in Philadelphia, 1976 (Fraser, et al., 
1977; Mercante, et al., 2016). Additional 19 isolates of the same ST36 described by 
Mercante et al. were identical to the Philadelphia-1 strain for these 40 targets (data not 
shown) (Mercante, et al., 2016). Furthermore, three unrelated ST345 isolates (EULV1461; 
EULV1647 and EULV1654) are highly similar to the second cluster, ST345-B. We therefore 
assume that the ST345-B variant is the ancestral strain and the isolates of the ST345-A 
cluster evolved most probably by uptake of two large fragments from a donor strain in water 
systems. During the outbreak in Warstein environmental isolates of different sero- and mAb-
subgroups were screened, but not tested in more depth and unfortunately not stored for 
later analysis which makes it impossible to identify the donor of the recombined regions. 
Both ST345 clusters, ST345-A and ST345-B, which were identified during this 
outbreak, were identified in clinical and environmental sources. Several distinct potential 
environmental sources were confirmed that all harboured the epidemic clone including a 
CT, WWTPs and the river Wester that runs through the city of Warstein (Maisa, et al., 2015). 
ST345-A isolates were detected in all four environmental reservoirs (sources A–D) while 
ST345-B isolates were found in two of them (sources B and C). However, all sources are 
located close to each other and are connected to or use the water of the river Wester 
(source D). The extensive epidemiological investigations indicated that this outbreak must 
be regarded as a multifactorial event with more than one sole source of contamination. It 
cannot be excluded that ST345-B inhabited the remaining two sources as well but might not 
have been sampled or isolated during the outbreak. The final clarification regarding which 
source might have contaminated other sources or whether one source is the main source 
of infection may never be solved in detail. 
The suitability as well as the usability of a cgMLST to become a new standard typing 
method for L. pneumophila Sg1 isolates was recently discussed and requires further 
evaluation and refinement (Moran-Gilad, et al., 2015; David, et al., 2016a). Core genome 
MLST combines a high discriminatory level with a standardised workflow and nomenclature 
which enables a global comparability of isolates. The latter is an important keynote for the 
surveillance and epidemiological investigation of LD wherein travel-associated infections 
play a significant role (European Centre for Disease Prevention and Control, 2015b). Thus, 
having the same typing tool is crucial. Combining knowledge on international level to define 
a robust scheme, a comprehensible workflow and uniform interpretation of data is 
mandatory. This is currently being mitigated by an international working group set up by the 
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European Study Group for Legionella Infections (ESGLI) to ensure that cgMLST is globally 
implemented in a fit-for-purpose manner while maintaining backwards compatibility 
(Gordon, et al., 2017). 
Conclusion 
Application of the cgMLST scheme for L. pneumophila demonstrated its usability 
during outbreak investigations. Core genome MLST showed a superior discriminatory 
power when compared with current gold standard typing methods, allowing for a higher 
resolution which resulted in finding that the epidemic strain split up into two variants. 
Furthermore, cgMLST indicated horizontal gene transfer as potential reason for the 
difference between both variants. This was confirmed by additional bioinformatics analyses. 
The value of classical epidemiological data was reinforced during the outbreak 
investigation, as such data anchored the isolates in time and space. These epidemiological 
data supported the findings that the large outbreak of LD in Warstein was caused by two 
variants, ST345-A and ST345-B, of the same ST345 clone. In the WGS era, cgMLST allows 
for a standardised workflow and nomenclature with high resolution and can even identify 
recombination events when allelic differences are clustered. However, the establishment of 
a globally uniform scheme needs to be well communicated and orchestrated in order to be 
cost-efficient and fit-for-purpose.  
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Part III - Comment 
The application of cgMLST to surveillance and outbreak investigations brings the 
molecular typing of L. pneumophila to the next (second and third) generation’s sequencing 
level. The cgMLST scheme used for L. pneumophila was initially described by Moran-Gilad 
and colleagues (2015). They tested the scheme using a few isolates of humidifier-related 
LD cases. The main focus of this work was to evaluate the method used during outbreak 
situations. I was able to use collected WGS data analyzed by the colleagues from Munster. 
In addition to the outbreaks described in Zweibrücken (2012) and Warstein (2013), 
two further outbreaks were analyzed in retrospective and support the benefit of the 
application.  
During the winter of 2002/2003 seven nosocomial LD cases were reported in a 
psychiatric ward in Germany (Ellsäßer and Hiller, 2004). All the patients resided in one 
section of a two-part building. Construction work on that section of the building had been 
completed two months before the outbreak occurred. Laboratory confirmation of the LD 
cases was limited to positive UATs on clinical samples. Isolates obtained from samples of 
the hot water drinking system were typed as L. pneumophila Sg1, mAb-subgroup Knoxville 
(ST182) and Philadelphia (ST1). Six months later, in June 2003, five LD cases were 
reported. This time all the cases were accommodated in the other part of the same building, 
which had once more been completed just two month before. This time respiratory 
specimens and drinking water samples were collected. Clinical isolates were typed as 
L. pneumophila Sg1, Knoxville, ST182. The water isolates showed the same 
characteristics. The second wave of infections was therefore caused by the ST182 strain, 
which was probably the causative strain of the first wave. For the cgMLST analysis, several 
environmental isolates were available from the first and second waves of infection, as well 
as from a routine follow up control in 2009 (Figure 13). Remarkably, the isolates showed a 
maximum of two different alleles. There was no significant difference between the strains 
of the two outbreak waves and the control isolate obtained six years later.  
Another interesting cluster occurred on a cruise ship in 2003 in which eight patients 
suffered from LD, one of them including died. Clinical isolates were obtained and the 
epidemic strain was typed as L. pneumophila Sg1, mAb-subgroup Knoxville, ST35. The 
outbreak strain was found in the spa-pool and in the shower hose of the ship’s hair-dresser 
(Beyrer, et al., 2007). Five years later, another LD patient was reported who was a 
passenger on a cruise ship during the incubation period (Hering, 2009). Despite the new 
name of the ship, the responsible public health authorities and the consultant laboratory for 
Legionella identified the cruise ship as the same ship. Laboratory investigations of the 
clinical and environmental samples confirmed the causative strain as ST35, mAb-subgroup 
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Knoxville, which was identical to that of the strain isolated five years before. The cgMLST 
indicates that the isolates obtained five years later did not differ from the initial clinical 
isolates (Figure 13).  
These scenarios demonstrated how cgMLST can be applied to outbreak 
investigations. Thus, the new method confirms current the gold standard methods. 
Furthermore, cgMLST represents a robust system. Isolates sampled several years apart 
cluster together, proving the stability of the cgMLST scheme’s targets. The analysis of 
alleles is not representative of a complete genome, and finding no allelic difference between 
two isolates does not necessarily exclude other mutations, deletions or insertions within the 
genome, irrespective of whether the seven alleles of SBT are used or 1,521 alleles of 
cgMLST. However, the chance of identifying mutations using the cgMLST scheme is 
significantly higher due to the number of targets. Therefore, it is remarkable that the isolates 
of the outbreaks in the psychiatric ward and the cruise ship do not differ, which indicates a 
rather slow mutation rate within the core genome. The rate of mutation for selected 
L. pneumophila strains was calculated as 0.49-071 SNPs per genome and year, thus three 
to five mutations per genome of the aforementioned outbreak strains. These SNPs might 
be not detected by cgMLST as the targets are well selected coding sequences and SNPs 
mainly occur in non-coding regions (Sánchez-Busó, et al., 2014; David, et al., 2016b). 
Furthermore, Coscollá and colleagues calculated that the rate of recombination is four times 
higher than the rate of mutation (Coscollá, et al., 2011). The cgMLST proved its suitability 
as an analysis tool during the outbreak scenarios and confirmed the current typing methods.  
Psychiatric ward Cruise Ship
A B
Figure 13: Core genome MLST analysis of two clusters of L. pneumophila Sg1 isolates. A) Isolates 
obtained during a biphasic outbreak in a psychiatric ward in 2003 in Frankfurt/Oder (Germany) characterized as 
ST182, mAb-subgroup Knoxville. The environmental isolate W03-025 was obtained during the first cluster of LD 
cases. The isolates W09-365-A and –B were collected in 2009 during follow up control. B) Isolates were obtained 
in two waves of LD cases on a cruise ship in 2003 and 2008 and characterized as ST35, mAb-subgroup 
Knoxville. ‘L’ represents clinical isolates, ‘W’ represents water samples. 1,400 cgMLST targets of 1,521 targets 
were analyzed.  
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In contrast to these outbreaks, the outbreak in Warstein revealed an unexpected 
feature of the cgMLST scheme. Core genome MLST distinguished the epidemic strain of 
the Warstein outbreak ST345 into two distinct clusters. Both clusters differed from each 
other by 40 alleles. Neither the current typing methods nor the newly developed DNA-
microarray were able to unravel the differences between the two clusters. A detailed 
analysis identified recombination events as the cause of the difference. The reason for the 
detection of the recombined regions was the core genome scheme itself. The close 
proximity of the selected 1,521 coding regions (average 2 genes between alleles; range 
1 to 128 genes) enabled the detection of large connected recombined regions. It should be 
noted here, that the arrangement of genes was based on the reference genome used and 
may vary among genomes. However, it appears unlikely that the genes that were arranged 
in close proximity in one strain show a completely different arrangement in another genome 
and that these genes also show allelic differences.  
In addition, several genomes of L. pneumophila were sequenced and analyzed in 
detail. The species L. pneumophila contains several molecular markers of horizontal gene 
transfer (HGT) or recombination. Furthermore, a large arsenal of genes of eukaryotic origin 
can be found within the genome, which may have been acquired by the HGT or by their 
convergent evolution from their hosts (Cazalet, et al., 2004; Lurie-Weinberger, et al., 2010; 
Gomez-Valero, et al., 2011a). It is generally assumed that recombination is the driving force 
that shapes the adaptation and virulence of L. pneumophila. Large recombination fragments 
have been described, which were up to 141 kb in size (Sánchez-Busó, et al., 2014). 
Recently, researchers from the Wellcome Trust Sanger Institute and the Institute Pasteur 
identified several hot-spots for homologous recombination. They point to multi-fragment 
recombination of L. pneumophila, which implies the incorporation of several DNA segments 
from the same donor DNA into the genome (David and Sánchez-Busó, et al., 2017). This is 
certainly a conceivable process since L. pneumophila is naturally capable of external DNA 
acquisition (Stone and Kwaik, 1999).  
Other cgMLST schemes of L. pneumophila have recently been reported (David, et 
al., 2016a; Raphael, et al., 2016). David and colleagues tested various target sets 
accurately, such as ribosomal genes and different sets of the core genome, including the 
set used in this work. Raphael and colleagues used a whole genome MLST pipeline of 
Bionumerics®, which is similar to the concept of cgMLST but uses many more targets. The 
conclusion drawn by all who applied a genome wide gene-by-gene typing approach was 
that a MLST-based method allows the assignment of traceable types and transferable 
results, which is important to the final user, usually public health authorities and reference 
laboratories. As consequence, a whole genome SNP-based method is not favorable as 
surveillance tool for legionellae (Maiden, et al., 2013).  
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Most importantly, a new typing scheme should have a higher resolution than the 
current methods and must fulfil the validation guidelines for molecular typing methods (Van 
Belkum, et al., 2007). Furthermore, epidemiological concordance is inversely correlated to 
resolution, which means that SNP-based whole genome analysis will (probably) always 
show differences between clinical and environmental isolates, and even between two 
isolates obtained from the same sample on the same day (Ensminger, et al., 2012). Thus, 
the trade-off between epidemiological concordance and resolution should be fathomed to 
allow surveillance and typing. Moreover, bioinformatic pipelines should be built-up and 
maintained. Similarly to the current SBT database, an online tool is preferred that assigns 
a core genome sequence type after the submission of WGS raw data, and provides further 
supportive information, for example, concerning putative HGT events or similarities to other 
strains (Schjørring, et al., 2017). In addition, during times of big data, the storage of huge 
amounts of WGS data needs be included in the bioinformatics pipeline (central vs. local 
storage; backup). A new method should maintain backward compatibility in order to obtain 
STs of SBT. Likewise, the multicopy dilemma of mompS needs to be solved 
bioinformatically (Moran-Gilad, et al., 2015; Gordon, et al., 2017).  
An international group of Legionella-epidemiologists and molecular analysts has 
been formed to establish a new gene-by-gene typing approach for L. pneumophila and 
L. longbeachae, and to deal with the above issues. 
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Part IV - Conclusion 
Understanding the ecology, and hence the distribution, of pathogenic bacteria is 
fundamental if epidemiologists are to keep pace with the rapidly evolving organisms. Many 
aspects need to be taken into account. Models have been developed of the infection and 
amplification of the bacteria, their physiological response to environmental stressors, their 
evolution and the co-evolution of their natural hosts, and the global spread of bacteria. Since 
the discovery of the genetic code, these topics have been accompanied and supported by 
molecular tools. In recent years, the molecular analysis of infectious diseases has 
undergone a remarkable transformation from phenotypic methods to gene or genome 
based methods. These tools currently deliver an immense data amount of information that 
needs to be analysed, understood and interpreted until a complete picture of a pathogen’s 
lifestyle can be drawn, which will probably never occur.  
An important aspect of surveillance and epidemiological investigations is the 
collection of as much information as possible concerning the patients who suffers from the 
disease. Classical epidemiology uses parameters such as time, place and person to identify 
epidemiological links. However, it is not only the affected person who is screened. The 
triggering pathogen itself and its environmental habitat also needs to be analysed in much 
detail as possible. Clinical microbiology allows the identification of the species and 
molecular typing methods are useful for characterizing and categorizing the pathogen.  
Legionellae is a versatile pathogen in terms of possible study fields, which range 
from intracellular replication to biofilm formation, and from secreting virulence factors to co-
evolution with its natural hosts. Within four decades, since the initial description of 
legionellae as a public health threat, knowledge concerning this pathogen has grown from 
day to day. However, the reported cases of LD have also increased each year, which is 
largely due to a higher awareness of this bacterium in health care institutions.  
The isolation of legionellae by means of cultivation still represents a serious obstacle. 
An isolate forms the basis for further typing methods, which allow a comparison between 
clinical and environmental samples. Culture independent typing methods are limited to the 
detection of soluble antigen (e.g. urinary antigen tests) and DNA via PCR. However, these 
methods usually only provide information about presence or absence of the bacteria in the 
sample analysed. For legionellae, several typing techniques based on the isolated bacteria 
were evaluated and a gold standard method was finally validated and determined. For 
several years, SBT and mAb-subgrouping served as the globally recognized 
epidemiological typing scheme. Neither system runs perfectly, but they are acceptable in 
the absence of any better tool. The major shortcoming of current methods, namely their 
limited discriminatory resolution, has been frequently discussed in recent years. They do 
not deliver satisfactory typing results, particularly in the case of endemic clones such as the 
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ST48, ST37 and ST62 or globally spread clones such as ST1 SBT, even in combination 
with phenotypic serogrouping (Ginevra, et al., 2012; Lück, et al., 2015; Mentasti, et al., 
2017). Several in-house methods have been developed by local laboratories that deal with 
undistinguishable clones. ThThe validation and introduction of a new molecular typing tool 
needs to achieve several standard parameters, including a satisfactory discriminatory 
power and the reproducibility and transferability of the results between laboratories (Van 
Belkum, et al., 2007).  
The results presented in this work focus on the current limitations of L. pneumophila 
typing, such as the non-distinctiveness of globally spread STs and dominant endemic 
clones. In this respect, it is of utmost importance to maintain a high level of discrimination 
without losing epidemiological concordance, a common problem when molecular resolution 
increases. Furthermore, attention should be paid to a new method’s working capability in 
routine laboratories and its performance during labour-intensive investigations such as 
outbreaks. It is necessary to validate and compare a newly implemented tool using current 
methods. The known deficits should be compensated without the introduction of new 
shortcomings or bottlenecks.  
Both methods use whole genome DNA and both methods ‘map’ the DNA to a 
predefined template. The template used on the microarray is a single-stranded DNA-probe 
and represents a rather physiochemical-based mapping. By contrast, the cgMLST template 
is an in silico sequence that is compared to the sequence of the screened isolate. Both 
‘mapping patterns’ can be translated into transferable codes (hybridization pattern for the 
microarray or cgMLST sequence type for the cgMLST-scheme). 
The development of a DNA-hybridization based microarray was validated against 
current gold standard methods and passed all the demands for molecular typing: the index 
of discrimination is higher than that of the SBT and mAb-based subgrouping, the hands on 
time is comparable to these methods, the results are transferable and reproducible, and 
their output user-friendly (Gaia, et al., 2005; Krause, 2014; David, et al., 2016a). The study 
sought to implement DNA-based subgrouping of the L. pneumophila Sg1 isolates, which is 
usually done phenotypically using mAbs. The assignment of isolates to the virulent ‘Pontiac 
group’ on molecular basis may be an essential step in the screening procedures of 
environmental and clinical isolates. In addition, four of the nine L. pneumophila Sg1 
subgroups can clearly be distinguished by specific hybridization patterns. The subgroups 
Philadelphia and Allentown/France, as well as the very rare isolated subgroups Heysham, 
Camperdown and Oxford were indistinguishable by the DNA-microarray. Similarly, the 
assignment of mAb-subgroups also allows the microarray to partially assign STs to an 
isolate. However, the classification is limited to STs that are clearly distinct from each other. 
By contrast, heterogeneous STs, such as the ST1, are separated in subgroups. This 
enables differentiation between frequently found isolates that are characterized as ST1, 
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mAb-subgroup OLDA. The DNA-microarray combines several abilities, such as the 
subgrouping of isolates, a rough ST assignment and the higher resolution of large 
heterogeneous ST, which were not distinguishable by the current methods. Thus, the DNA-
microarray represents an optimized screening tool for larger sample volumes, particularly 
when the time window is narrow.  
The initial idea to rather transfer the phenotypic mAb-based subgrouping to a 
molecular level succeeded partially by implementing specific probes onto the DNA-
microarray. In addition, the focus was to identify the molecular traits of specific ST and mAb-
subgroup combinations, and to find the molecular correlation between a particular ST and 
its LPS phenotype. The hierarchical analysis of hybridization patterns allows the division of 
isolates of the same ST into different subgroups. Multiple clusters of the same ST and 
subgroup that differed from each other were still observed, and however, some 
ST/subgroup combinations were very similar to each other. This indicates that mAb-
subgroups, and hence the LPS-biosynthesis loci, do not correlate with STs. David and 
coworkers recently described the LPS-biosynthesis region as a hotspot for homologous 
recombination. This explanation supports the incongruence between the STs and mAb-
subgroups of the L. pneumophila Sg1 isolates (David, et al., 2017). 
The evaluation of the cgMLST during outbreak investigations proved the applicability 
of this tool. The selection of the cgMLST scheme’s 1,521 genes was based on Underwood 
and co-workers who determined the core genome of L. pneumophila Sg1 (Underwood, et 
al., 2013). The analysis of the population structure based on the core genome largely 
agreed with the population analysis based on SBT. A detailed validation of the scheme was 
performed by David and colleagues, who found that the index of discrimination was higher 
than that of current gold standard methods (IOD of cgMLST: 0.999). However, they further 
reported that only 40 % of the analysed strains were fully typeable, which means that only 
a proportion of genomes carry all the 1,521 genes. This may be due to a larger set of 
accessory genes within the scheme that are difficult to sequence and/or assemble, or these 
genes may generally be absent in the analysed genomes (David, et al., 2016a). A group of 
experts in the field of molecular typing and Legionella is currently being established to verify 
the perfect set of core genes. Remarkably, the scheme used in this work reflects the 
genome of L. pneumophila in extraordinary depth. In this way, the identification of large 
genome arrangements such as recombination events becomes visible. It had generally 
been assumed that the expansion of L. pneumophila follows a rather clonal pattern with 
little diversification due to the low extent of recombination. However, recent studies support 
the more complex genome plasticity of the L. pneumophila genomes, with several 
exchangeable regions of other serogroups and even eukaryotic hosts (David, et al., 2017).  
The WGS data that form the basis for the cgMLST allows, albeit bioinformatically 
challenging, backward compatibility for the determination of allele numbers of the classic 
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SBT. With the introduction of WGS, a new flood of information concerning the ecology and 
spread of L. pneumophila became visible which lead to paradigm shifts. In comparison to 
the current methods and the DNA-microarray presented here, the cgMLST allows the 
assignment of both, the classic ST and a core genome ST. However, it remains depending 
on the implementation of further tools that are able to detect recombination events. 
Moreover, the generation of genome data requires huge storage capacities, an issue that 
has not yet been adequately tackled.  
In general, both methods fulfil the guidelines for molecular typing methods. They 
represent current laboratory standards and have a balanced trade-off between molecular 
resolution and epidemiological concordance.  
With regard to the laboratory-analytic chain of the analysis of one isolate, starting 
from sample processing to the analysis of final results, both methods can be performed 
within one workday. The use of current sequencing machines for cgMLST means that the 
sequencing coverage per nucleotide allows a robust and reliable interpretation of the 
results. By contrast, the DNA-microarray requires physically repeated experiments to 
increase the reliability of the results. Repeated experiments on the same genome show 
differences between hybridization patterns up to 4 %, which must be taken into account 
during data interpretation. A fully automated interpretation of the results can be 
implemented into the analysis-pipeline for both methods, leading to the assignment, for 
example, of clonal groups (DNA-microarray) or a core genome ST. Additional information 
can be extracted from the raw results, such as a DNA-based subgroup (DNA-microarray), 
the classical ST or an indication of the recombination events (cgMLST).  
It is very likely, that future molecular typing methods rely on WGS data. The complete 
sequenced genomes provide information that are not only useful during the diagnosis of LD 
patients, but provide also information that are required for the identification of the source of 
infection and the epidemiological tracing of single strains or outbreaks. It is important to 
establish a typing method which is globally accepted. Whole genome sequencing supports 
a robust scheme for the legionella typing, and allows hierarchical levels that provide the 
users and epidemiologist a deeper insight into certain isolates. However, WGS is currently 
performed by specialized reference centers. For laboratories that are not equipped with 
NGS-experienced staff or that do not have the money to use these machines routinely, the 
DNA-microarray represents an alternative to NGS and is certainly an advantage to current 
typing methods with regard to a fast and reliable molecular analysis during outbreak 
investigations and routine analyses.  
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µg microgram 
µl microliter 
µmol micromole 
AFLP amplified fragment length polymorphism 
amb ambiguous 
B background 
BAL broncho-alveolar lavage 
BCYE buffered charcoal yeast extract 
BLAST (BLASTP) Basic Local Alignment Search Tool (Protein BLAST) 
BMPA BCYE with cefamandole, plymyxin B and anisomycin 
CAP community acquired pneumonia 
CDC Centers for Disease Control and Prevention 
cgMLST core genome multilocus sequence typing 
CI confidence interval 
clin. clinical 
cm centimeter 
CMP-5,7-diacetamido-3,5,7,9-tetradeoxy-
D-glycero-D-talo-nonulosonic acid CMP-Leg5Ac7Ac 
CMP-5-acetamidino-7-acetamido-3,5,7,9-
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CMP-Leg5Am7Ac 
CMP-5-acetimidoyl (N-methyl) amino-7-
acetamido-3,5,7,9-tetradeoxynon-2-
ulosonic acid 
CMP-Leg5AmNMe7Ac 
CO2 carbon dioxide 
cooling tower CT 
COPD chronic obstructive respiratory disease 
CRISPR clustered regularly interspaced short palindromic repeats 
defect of organelle trafficing/intra cellular 
multipliction Dot/icm 
DFA direct fluorescent antibody test 
DNA deoxyribonucleic acid 
Dot/Icm defect in the organelle trafficking/intracellular multiplication 
dUTP deoxyuridine triphosphate 
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ELDSNet European Legionnaires' disease network 
ECDC European Center for Disease Prevention and Control 
ELISA Enzyme-linke immunosorbend assay 
EMBL European Molecular Biology Laboratory 
env. environmental 
ER endoplasmatic reticulum 
ESGLI 
ESCMID (European Society of Clinical 
Microbiology and Infectious Disease) 
Study Group for Legionella Infections 
et al. et alii (and others) 
etc. et cetera (and the rest) 
EUL European Legionella reference strains 
e.g. exempli gratia (for example) 
FF filamentous form 
GC guanine/cytosine 
GIS geographic information system 
GlcNAc N-acetyl-glucosamine 
h hour 
HGT horizontal gene transfer 
HP hybridization profile 
ID identity 
i.e. id est (that is) 
IOD index of discriminatory power 
ISO International Organization for Standardization 
kb kilobase 
L liter 
L (in e.g. L13-438) Legionella (clinical legionellae isolate) 
LCV Legionella containing vacuole 
LD Legionnaires' Disease 
Lp Legionella pneumophila 
LPS lipopolysaccharide 
M mean intensity 
mAb monoclonal antibody 
MIF Mature intracellular form 
min minute 
MLST multilocus sequence typing 
mRNA messenger ribonucleic acid 
MST minimum spanning tree 
n number 
NA Not applicable 
ND Not detected 
neg negative 
NGS next generation sequencing 
NI normalized intensity 
nSBT nested sequence based typing 
ORF open reading frame 
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PCR polymerase chain reaction 
PFGE pulsed-field gel electrophoresis 
PHE Public Health England 
pos positive 
QuiNAc N-acetyl-quinovosamine 
s second 
SAM S-adenosylmethionine 
SBT sequence-based typing 
Sg serogroup 
SNP single nucleotide polymorphism 
spp. species pluralis 
ST sequence type 
UAT urinary antigen test 
UDP-N,N’-diacetylbacillosamine UDP-Bac2Ac4Ac 
UPGMA Unweighted Pair Group Method with Arithmetric mean 
V Volt 
VBNC viable but non-culturable 
W (in e.g. W13-845) water (environmental legionellae isolate) 
WGS whole genome sequencing 
WWTP waste water treatment plant 
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